Table of Contents

UNITED STATES

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 10-Q

FORM 10-Q

(Mark One)

xQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2017March 31, 2022

OR

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

oTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number 0-16244


VEECO INSTRUMENTS INC.

(Exact Name of Registrant as Specified in Its Charter)

Delaware

11-2989601

(State or Other Jurisdiction of Incorporation or Organization)

11-2989601
(I.R.S. Employer Identification No.)

Terminal Drive

Plainview, New York

11803

(Address of Principal Executive Offices)

11803
(Zip Code)

Registrant’s telephone number, including area code:

(516) (516) 677-0200

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.01 per share

VECO

The NASDAQ Global Select Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes x  No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).        Yes    x.Yes   No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”filer,” “smaller reporting company”company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filero

    

Accelerated filer x

Non-accelerated filero  (Do not check if a smaller reporting company)

    

Accelerated filer 

Non-accelerated filer 

Smaller reporting company o

Emerging growth company o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes o  No x

Indicate the numberAs of May 2, 2022, there were 51,243,012 shares outstanding of each of the issuer’s classes ofregistrant’s common stock asoutstanding.


Safe Harbor Statement

This quarterly report on Form 10-Q (the “Report”) contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Discussions containing such forward-looking statements may be found in Part I - Items 1, 2, and 3 hereof, as well as within this Report generally. In addition, when used in this Report, the words “believes,” “anticipates,” “expects,” “estimates,” “targets,” “plans,” “intends,” “will,” and similar expressions related to the future are intended to identify forward-looking statements. All forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from projected results.

In addition, the preparation of financial statements in conformity with U.S. Generally Accepted Accounting Principles (“U.S. GAAP”) requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Although these estimates and assumptions are based on knowledge of current events, including the potential impact of the COVID-19 pandemic on our business, and planned actions to be undertaken in the future, they may ultimately differ from actual results. Operating results for the ninethree months ended September 30, 2017March 31, 2022 are not necessarily indicative of the results that may be expected for the year ending December 31, 2017. 2022. All estimates and assumptions are subject to a number of risks and uncertainties that could cause actual results to differ materially from these estimates and assumptions.

The risks and uncertainties of Veeco Instruments Inc. (together with its consolidated subsidiaries, “Veeco,” the “Company,” “we,” “us,” and “our,” unless the context indicates otherwise) include, without limitation, the following:

·                  Unfavorable market conditions may adversely affect our operating results;

·                  A reduction or elimination of foreign government subsidies and economic incentives may adversely affect the future order rate for our MOCVD equipment;

·                  The cyclicality of the industries we serve directly affects our business;

·                  We operate in industries characterized by rapid technological change;

·                  We have a concentrated customer base, located primarily in a limited number of regions, which operate in highly concentrated industries;

·                  We face significant competition;

·                  The timing of our orders, shipments, and revenue recognition may cause our quarterly operating results to fluctuate significantly;

·                  Our sales cycle is long and unpredictable;

·                  Our backlog is subject to customer cancellation or modification which could result in decreased sales, increased inventory obsolescence, and/or liabilities to our suppliers for products no longer needed;

·                  Our failure to estimate customer demand accurately could result in inventory obsolescence, liabilities to our suppliers for products no longer needed, and/or manufacturing interruptions or delays which could affect our ability to meet customer demand;

·                  Our failure to successfully manage our outsourcing activities or failure of our outsourcing partners to perform as anticipated could adversely affect our results of operations and our ability to adapt to fluctuating order volumes;

·                  We rely on a limited number of suppliers, some of whom are our sole source for particular components;

·                  Our inability to attract, retain, and motivate employees could have a material adverse effect on our business;

·                  Our acquisition strategy subjects us to risks associated with evaluating and pursuing these opportunities and integrating these businesses;

·                  Timing of market adoption of LED technology for general lighting is uncertain;

·                  Our sales to manufacturers are highly dependent on sales of consumer electronics applications, which can experience significant volatility due to seasonal and other factors and materially adversely impact our future results of operations;

·                  Our operating results have been, and may continue to be, adversely affected by tightening credit markets;

·                  We are exposed to the risks of operating a global business, including the need to obtain export licenses for certain of our shipments and political risks in the countries we operate;

·                  We may be exposed to liabilitiesthose set forth under the Foreign Corrupt Practices Actheading “Risk Factors” Part 1, Item 1A in our 2021 Form 10-K, and any determination that we violated these or similar lawsthe following:

Risks Related to Our Business, Finance and Operations

The effects of the COVID-19 pandemic have strained and have negatively impacted our business and operations, and the duration and extent to which COVID-19 may impact our future results of operations and overall financial performance remains uncertain;

Unfavorable market conditions have adversely affected, and may continue to adversely affect, our operating results;

The timing of our orders, shipments, and revenue recognition may cause our quarterly operating results to fluctuate significantly;

Our sales cycle is long and unpredictable;

Our backlog is subject to customer cancellation or modification which could result in decreased sales, increased inventory obsolescence, and liabilities to our suppliers for products no longer needed;

We may be required to take impairment charges on assets;

We are exposed to risks associated with business combinations, acquisitions, strategic investments and divestitures;

We have adopted certain measures that may have anti-takeover effects which may make an acquisition of our Company by another company more difficult;

Our current debt facilities, including our 2.70% Convertible Senior Notes due 2023 (the “2023 Notes”), our 3.50% Convertible Senior Notes due 2025 (the “2025 Notes”), or our 3.75% Convertible Senior Notes due 2027 (the “2027 Notes”) (the 2023 Notes, 2025 Notes, and 2027 Notes, together, the “Notes”), and our revolving credit facility (the “Credit Facility”), may contain certain restrictions, covenants and repurchase provisions that may limit our ability to raise the funds necessary to meet our working capital needs, which may include the cash conversion of the Notes or repurchase of the Notes for cash upon a fundamental change;

1

The conditional conversion features of the 2023 Notes, 2025 Notes, and 2027 Notes, if triggered, may materially and adversely affect our financial condition and operating results;

The accounting method for convertible debt securities that may be settled in cash, such as the Notes, could have a material effect on our reported financial results;

Issuance of our common stock, if any, upon conversion of the Notes, as well as the capped call transactions and the hedging activities of the option counterparties, may impair or reduce our ability to utilize our net operating loss carryforwards or our research and development credits carryforwards in the future;

The capped call transactions may affect the value of the 2027 Notes and our common stock;

Risks Associated with Operating a material adverse effect on our business;Global Business

We are exposed to risks of operating businesses outside the United States;

Changes in U.S. trade policy and export controls and ongoing trade disputes between the U.S. and China have adversely affected, and may continue to adversely affect, our business, results of operations, and financial condition;

We may be unable to obtain required export licenses for the sale of our products;

We are exposed to various risks associated with global regulatory requirements;

We may be exposed to liabilities under the Foreign Corrupt Practices Act and other similar laws;

Our operating results may be adversely affected by tightening credit markets;

We are subject to foreign currency exchange risks;

·                  We are subjectRisks Related to internal control evaluationsIntellectual Property and attestation requirementsCybersecurity

Disruptions in our information technology systems or data security incidents could result in significant financial, legal, regulatory, business, and reputational harm to us;

We may be unable to effectively enforce and protect our intellectual property rights;

We may be subject to claims of intellectual property infringement by others;

Risks Associated with Our Industry

We face significant competition;

We operate in industries characterized by rapid technological change;

Certain of our sales are dependent on the demand for consumer electronic products and automobiles, which can experience significant volatility;

We have a concentrated customer base, located primarily in a limited number of regions, which operates in highly concentrated industries;

The cyclicality of the industries we serve directly affects our business;

2

Our failure to estimate customer demand accurately could result in inventory obsolescence, liabilities to our suppliers for products no longer needed, and manufacturing interruptions or delays which could affect our ability to meet customer demand;

��

We rely on a limited number of suppliers, some of whom are our sole source for particular components;

Our failure to successfully manage our outsourcing activities or failure of our outsourcing partners to perform as anticipated could adversely affect our results of operations;

General Risk Factors

·                  Changes in accounting pronouncements or taxation rules or practices may adversely affect our financial results;

The price of our common shares is volatile and could decrease;

We are subject to risks of non-compliance with environmental, health, and safety regulations and sustainability requirements;

·                  Our income taxes can change;

Our inability to attract, retain, and motivate employees could have a material adverse effect on our business; and

Changes in accounting pronouncements or taxation rules, practices, or rates may adversely affect our financial results.

·                  We may be required to take additional impairment charges on assets;

·                  We have indebtedness in the form of convertible senior notes which could adversely affect our financial position, prevent us from implementing our strategy, and dilute the ownership interest of our existing shareholders;

·                  The accounting method for convertible debt securities that may be settled in cash, such as the Convertible Senior Notes, could have a material effect on our reported financial results;

·                  The price of our common shares is volatile and could decline significantly;

·                  The enforcement and protection of our intellectual property rights may be expensive and/or divert our limited resources;

·                  We may be subject to claims of intellectual property infringement by others;

·                  We are subject to foreign currency exchange risks;

·                  If we are subject to cyber-attacks we could incur substantial costs and, if such attacks are successful, we could incur significant liabilities, reputational harm, and disruption to our operations;

·                  We have adopted certain measures that may have anti-takeover effects which may make an acquisition of our Company by another company more difficult;

·                  We are subject to risks of non-compliance with environmental, health, and safety regulations;

·                  Regulations related to conflict minerals will force us to incur additional expenses, may make our supply chain more complex, and may result in damage to our relationships with customers;

·                  We have significant operations in locations which could be materially and adversely impacted in the event of a natural disaster, an act of terrorism or other significant disruption; and

·                  We may not be able to successfully integrate the business of Ultratech with our own or realize the anticipated benefits of the merger.

Consequently, such forward looking statements and estimates should be regarded solely as the current plans and beliefs of Veeco. We do not undertake any obligation to update any forward looking statements to reflect future events or circumstances after the date of such statements.

3

PART I—IFINANCIAL INFORMATION

Item 1. Financial Statements

Veeco Instruments Inc. and Subsidiaries

Consolidated Balance Sheets

(in thousands, except share amounts)

March 31,

December 31,

    

2022

    

2021

Assets

(unaudited)

Current assets:

Cash and cash equivalents

$

127,624

$

119,747

Restricted cash

688

725

Short-term investments

 

103,277

 

104,181

Accounts receivable, net

 

99,479

 

109,609

Contract assets

25,602

18,293

Inventories

 

179,066

 

170,858

Prepaid expenses and other current assets

34,214

25,974

Total current assets

 

569,950

 

549,387

Property, plant, and equipment, net

 

104,128

 

99,743

Operating lease right-of-use assets

27,800

28,813

Intangible assets, net

31,401

33,905

Goodwill

 

181,943

 

181,943

Deferred income taxes

1,639

1,639

Other assets

 

3,503

 

3,546

Total assets

$

920,364

$

898,976

Liabilities and stockholders' equity

Current liabilities:

Accounts payable

$

56,154

$

44,456

Accrued expenses and other current liabilities

 

80,920

 

79,752

Customer deposits and deferred revenue

 

61,893

 

63,136

Income taxes payable

 

1,633

 

1,860

Current portion of long-term debt

 

20,096

 

Total current liabilities

 

220,696

 

189,204

Deferred income taxes

 

4,780

 

4,792

Long-term debt

 

253,840

 

229,438

Long-term operating lease liabilities

32,410

32,834

Other liabilities

 

5,068

 

5,080

Total liabilities

 

516,794

 

461,348

Stockholders' equity:

Preferred stock, $0.01 par value; 500,000 shares authorized; 0 shares issued and outstanding.

 

Common stock, $0.01 par value; 120,000,000 shares authorized; 51,243,012 shares issued and outstanding at March 31, 2022 and 50,652,864 shares issued and outstanding at December 31, 2021

 

513

 

507

Additional paid-in capital

 

1,057,808

 

1,116,921

Accumulated deficit

 

(655,412)

 

(681,283)

Accumulated other comprehensive income

 

661

 

1,483

Total stockholders' equity

 

403,570

 

437,628

Total liabilities and stockholders' equity

$

920,364

$

898,976

 

 

September 30,

 

December 31,

 

 

 

2017

 

2016

 

 

 

(unaudited)

 

 

 

Assets

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

235,268

 

$

277,444

 

Short-term investments

 

85,853

 

66,787

 

Accounts receivable, net

 

113,795

 

58,020

 

Inventories

 

113,681

 

77,063

 

Deferred cost of sales

 

17,594

 

6,160

 

Prepaid expenses and other current assets

 

36,396

 

16,034

 

Total current assets

 

602,587

 

501,508

 

Property, plant and equipment, net

 

84,403

 

60,646

 

Intangible assets, net

 

383,596

 

58,378

 

Goodwill

 

308,529

 

114,908

 

Deferred income taxes

 

2,528

 

2,045

 

Other assets

 

25,263

 

21,047

 

Total assets

 

$

1,406,906

 

$

758,532

 

 

 

 

 

 

 

Liabilities and stockholders’ equity

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable

 

$

53,716

 

$

22,607

 

Accrued expenses and other current liabilities

 

65,728

 

33,201

 

Customer deposits and deferred revenue

 

107,636

 

85,022

 

Income taxes payable

 

4,171

 

2,311

 

Current portion of long-term debt

 

 

368

 

Total current liabilities

 

231,251

 

143,509

 

Deferred income taxes

 

46,268

 

13,199

 

Long-term debt

 

272,825

 

826

 

Other liabilities

 

11,033

 

6,403

 

Total liabilities

 

561,377

 

163,937

 

Stockholders’ equity:

 

 

 

 

 

Preferred stock, $0.01 par value; 500,000 shares authorized; no shares issued and outstanding

 

 

 

Common stock, $0.01 par value; 120,000,000 shares authorized; 48,294,284 and 40,714,790 shares issued at September 30, 2017 and December 31, 2016, respectively; 48,294,284 and 40,588,194 shares outstanding at September 30, 2017 and December 31, 2016, respectively.

 

483

 

407

 

Additional paid-in capital

 

1,050,994

 

763,303

 

Accumulated deficit

 

(207,760

)

(168,583

)

Accumulated other comprehensive income

 

1,812

 

1,777

 

Treasury stock, at cost, 126,596 shares at December 31, 2016.

 

 

(2,309

)

Total stockholders’ equity

 

845,529

 

594,595

 

Total liabilities and stockholders’ equity

 

$

1,406,906

 

$

758,532

 

See accompanying Notes to the Consolidated Financial Statements.Statements.

4

Veeco Instruments Inc. and Subsidiaries

Consolidated Statements of Operations

(in thousands, except per share amounts)

(unaudited)

 

 

Three months ended September 30,

 

Nine months ended September 30,

 

 

 

2017

 

2016

 

2017

 

2016

 

Net sales

 

$

131,872

 

$

85,482

 

$

341,324

 

$

238,842

 

Cost of sales

 

78,811

 

52,027

 

215,344

 

141,991

 

Gross profit

 

53,061

 

33,455

 

125,980

 

96,851

 

Operating expenses, net:

 

 

 

 

 

 

 

 

 

Research and development

 

24,061

 

19,892

 

57,669

 

63,545

 

Selling, general, and administrative

 

29,771

 

18,396

 

71,574

 

58,230

 

Amortization of intangible assets

 

12,500

 

5,261

 

21,722

 

15,785

 

Restructuring

 

5,010

 

1,798

 

9,605

 

3,993

 

Acquisition costs

 

783

 

 

16,277

 

 

Asset impairment

 

2

 

56,035

 

1,139

 

69,662

 

Other, net

 

(140

)

795

 

(228

)

884

 

Total operating expenses, net

 

71,987

 

102,177

 

177,758

 

212,099

 

Operating income (loss)

 

(18,926

)

(68,722

)

(51,778

)

(115,248

)

Interest income

 

357

 

283

 

1,933

 

879

 

Interest expense

 

(5,105

)

(23

)

(14,301

)

(166

)

Income (loss) before income taxes

 

(23,674

)

(68,462

)

(64,146

)

(114,535

)

Income tax expense (benefit)

 

(1,790

)

1,136

 

(24,969

)

2,677

 

Net income (loss)

 

$

(21,884

)

$

(69,598

)

$

(39,177

)

$

(117,212

)

 

 

 

 

 

 

 

 

 

 

Income (loss) per common share:

 

 

 

 

 

 

 

 

 

Basic

 

$

(0.47

)

$

(1.78

)

$

(0.91

)

$

(2.99

)

Diluted

 

$

(0.47

)

$

(1.78

)

$

(0.91

)

$

(2.99

)

 

 

 

 

 

 

 

 

 

 

Weighted average number of shares:

 

 

 

 

 

 

 

 

 

Basic

 

46,941

 

39,131

 

43,100

 

39,193

 

Diluted

 

46,941

 

39,131

 

43,100

 

39,193

 

See accompanying Notes to the Consolidated Financial Statements.

Veeco Instruments Inc. and Subsidiaries

Consolidated Statements of Comprehensive Income (Loss)

(in thousands)

(unaudited)

 

 

Three months ended September 30,

 

Nine months ended September 30,

 

 

 

2017

 

2016

 

2017

 

2016

 

Net income (loss)

 

$

(21,884

)

$

(69,598

)

$

(39,177

)

$

(117,212

)

Other comprehensive income, net of tax

 

 

 

 

 

 

 

 

 

Unrealized gain (loss) on available-for-sale securities

 

70

 

(7

)

10

 

32

 

Minimum pension liability

 

 

866

 

 

866

 

Foreign currency translation

 

1

 

(7

)

25

 

20

 

Total other comprehensive income, net of tax

 

71

 

852

 

35

 

918

 

 

 

 

 

 

 

 

 

 

 

Comprehensive income (loss)

 

$

(21,813

)

$

(68,746

)

$

(39,142

)

$

(116,294

)

See accompanying Notes to the Consolidated Financial Statements.

Three months ended March 31,

    

2022

    

2021

    

Net sales

$

156,426

$

133,714

Cost of sales

 

90,413

 

78,800

Gross profit

 

66,013

54,914

Operating expenses, net:

Research and development

 

24,117

 

21,844

Selling, general, and administrative

 

22,894

 

20,255

Amortization of intangible assets

 

2,504

 

3,354

Other operating expense (income), net

(19)

46

Total operating expenses, net

49,496

45,499

Operating income

 

16,517

 

9,415

Interest income

 

89

 

136

Interest expense

 

(2,892)

 

(6,759)

Income before income taxes

 

13,714

2,792

Income tax expense (benefit)

 

384

 

298

Net income

$

13,330

$

2,494

Income per common share:

Basic

$

0.27

$

0.05

Diluted

$

0.24

$

0.05

Weighted average number of shares:

Basic

 

49,614

 

48,624

Diluted

 

65,285

 

53,050

Veeco Instruments Inc. and Subsidiaries

Consolidated Statements of Cash Flows

(in thousands)

(unaudited)

 

 

Nine months ended September 30,

 

 

 

2017

 

2016

 

Cash Flows from Operating Activities

 

 

 

 

 

Net income (loss)

 

$

(39,177

)

$

(117,212

)

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:

 

 

 

 

 

Depreciation and amortization

 

32,295

 

26,010

 

Non-cash interest expense

 

7,641

 

 

Deferred income taxes

 

(21,235

)

1,529

 

Share-based compensation expense

 

19,976

 

12,133

 

Asset impairment

 

1,139

 

69,662

 

Provision for bad debts

 

99

 

160

 

Changes in operating assets and liabilities:

 

 

 

 

 

Accounts receivable

 

(10,409

)

(1,184

)

Inventories and deferred cost of sales

 

9,486

 

(10,909

)

Prepaid expenses and other current assets

 

(331

)

3,661

 

Accounts payable and accrued expenses

 

3,165

 

(13,995

)

Customer deposits and deferred revenue

 

17,779

 

3,568

 

Income taxes receivable and payable, net

 

(16

)

 

Long-term income tax liability

 

(4,877

)

80

 

Other, net

 

(259

)

2,189

 

Net cash provided by (used in) operating activities

 

15,276

 

(24,308

)

 

 

 

 

 

 

Cash Flows from Investing Activities

 

 

 

 

 

Acquisitions of businesses, net of cash acquired

 

(399,478

)

 

Capital expenditures

 

(17,403

)

(10,717

)

Proceeds from the sale of investments

 

307,757

 

131,297

 

Payments for purchases of investments

 

(279,945

)

(78,376

)

Proceeds from held for sale assets

 

2,284

 

693

 

Other

 

 

(230

)

Net cash provided by (used in) investing activities

 

(386,785

)

42,667

 

 

 

 

 

 

 

Cash Flows from Financing Activities

 

 

 

 

 

Proceeds (net of tax withholdings) from option exercises and employee stock purchase plan

 

2,546

 

1,192

 

Restricted stock tax withholdings

 

(7,797

)

(1,184

)

Purchases of common stock

 

 

(13,349

)

Proceeds from long-term debt borrowings

 

335,752

 

 

Principal payments on long-term debt

 

(1,193

)

(252

)

Net cash provided by (used in) financing activities

 

329,308

 

(13,593

)

 

 

 

 

 

 

Effect of exchange rate changes on cash and cash equivalents

 

25

 

20

 

Net increase (decrease) in cash and cash equivalents

 

(42,176

)

4,786

 

Cash and cash equivalents - beginning of period

 

277,444

 

269,232

 

 

 

$

235,268

 

$

274,018

 

 

 

 

 

 

 

Supplemental Disclosure of Cash Flow Information

 

 

 

 

 

Interest paid

 

$

4,667

 

$

179

 

Income taxes paid

 

1,767

 

1,456

 

Non-cash operating and financing activities

 

 

 

 

 

Net transfer of inventory to property, plant and equipment

 

33

 

 

See accompanying Notes to the Consolidated Financial Statements.

5

Veeco Instruments Inc. and Subsidiaries

Consolidated Statements of Comprehensive Income

(in thousands)

(unaudited)

Three months ended March 31,

    

2022

    

2021

    

Net income

$

13,330

$

2,494

Other comprehensive income (loss), net of tax:

Unrealized gain (loss) on available-for-sale securities

 

(819)

 

11

Change in currency translation adjustments

 

(3)

 

(30)

Total other comprehensive income (loss), net of tax

 

(822)

 

(19)

Total comprehensive income

$

12,508

$

2,475

See accompanying Notes to the Consolidated Financial Statements.

6

Veeco Instruments Inc. and Subsidiaries

Consolidated Statements of Cash Flows

(in thousands)

(unaudited)

Three months ended March 31,

    

2022

    

2021

    

Cash Flows from Operating Activities

Net income

$

13,330

$

2,494

Adjustments to reconcile net income to net cash provided by (used in) operating activities:

Depreciation and amortization

 

6,240

 

6,822

Non-cash interest expense

238

3,514

Deferred income taxes

 

(16)

 

(4)

Share-based compensation expense

 

4,481

 

3,237

Changes in operating assets and liabilities:

Accounts receivable and contract assets

 

2,821

 

(6,811)

Inventories

 

(8,254)

 

(10,474)

Prepaid expenses and other current assets

 

(8,240)

 

(336)

Accounts payable and accrued expenses

 

14,773

 

12,612

Customer deposits and deferred revenue

 

(1,243)

 

1,672

Income taxes receivable and payable, net

 

(228)

 

172

Other, net

 

886

 

(2,413)

Net cash provided by (used in) operating activities

 

24,788

 

10,485

Cash Flows from Investing Activities

Capital expenditures

 

(10,918)

 

(1,953)

Proceeds from the sale of investments

 

2,260

 

55,385

Payments for purchases of investments

 

(2,498)

 

(52,037)

Net cash provided by (used in) investing activities

(11,156)

1,395

Cash Flows from Financing Activities

Proceeds (net of tax withholdings) from option exercises and employee stock purchase plan

 

998

 

878

Restricted stock tax withholdings

 

(6,787)

 

(1,625)

Net cash provided by (used in) financing activities

 

(5,789)

 

(747)

Effect of exchange rate changes on cash and cash equivalents

 

(3)

 

(30)

Net increase (decrease) in cash, cash equivalents, and restricted cash

 

7,840

 

11,103

Cash, cash equivalents, and restricted cash - beginning of period

 

120,472

 

130,283

Cash, cash equivalents, and restricted cash - end of period

$

128,312

$

141,386

Supplemental Disclosure of Cash Flow Information

Interest paid

$

2,593

$

1,803

Income taxes paid

523

240

Non-cash activities

Capital expenditures included in accounts payable and accrued expenses

6,253

2,138

Net transfer of inventory to property, plant and equipment

46

Right-of-use assets obtained in exchange for lease obligations

258

20,353

See accompanying Notes to the Consolidated Financial Statements.

7

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements

(unaudited)

Note 1 - Basis of Presentation

The accompanying unaudited Consolidated Financial Statements of Veeco have been prepared in accordance with U.S. GAAP as defined in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification 270 for interim financial information and with the instructions to Rule 10-01 of Securities and Exchange Commission Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements as the interim information is an update of the information that was presented in Veeco’s most recent annual financial statements. For further information, refer to Veeco’s Consolidated Financial Statements and Notes thereto included in the Annual Report on Form 10-K for the year ended December 31, 20162021 (“20162021 Form 10-K”). In the opinion of management, all adjustments considered necessary for a fair presentation have been included. All such adjustments are of a normal, recurring nature. Certain amounts previously reported have been reclassified in the financial statements to conform to the current presentation.

Veeco reports interim quarters on a 13-week basis ending on the last Sunday of each quarter. The fourth quarter always ends on the last day of the calendar year, December 31. The 20172022 interim quarters end on April 2, July 2, and October 1, and the 2016 interim quarters ended on April 3, July 3, and October 2.2, and the 2021 interim quarters ended on April 4, July 4, and October 3. These interim quarters are reported as March 31, June 30, and September 30 in Veeco’s interim consolidated financial statements.

Revenue recognition

Veeco recognizes revenue when allThe preparation of financial statements in conformity with U.S GAAP requires the Company’s management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Although these estimates are based on management’s knowledge of current events and actions it may undertake in the future, actual results may differ from these estimates. In particular, the COVID-19 pandemic has adversely impacted and is likely to further adversely impact the Company’s business and markets, including the Company’s workforce and operations and the operations of the following criteria have been met: persuasive evidenceCompany’s customers, suppliers, and business partners. The full extent to which the pandemic will directly or indirectly impact the Company's business, results of an arrangement exists with a customer; deliveryoperations and financial condition, including sales, expenses, manufacturing, research and development costs, reserves and allowances, fair value measurements, and asset impairment charges, will depend on future developments that are highly uncertain and difficult to predict. These developments include, but are not limited to, the duration and spread of the specified products has occurredoutbreak, its severity, the actions to contain the virus or services have been rendered; prices are contractually fixed or determinable;address its impact, governmental actions to contain the spread of the pandemic and collectability is reasonably assured. respond to the reduction in global economic activity, and how quickly and to what extent normal economic and operating conditions can resume.

Revenue Recognition

Revenue is recorded including shippingrecognized upon the transfer of control of the promised product or service to the customer in an amount that reflects the consideration the Company expects to receive in exchange for such product or service. The Company’s contracts with customers generally do not contain variable consideration. In the rare instances where variable consideration is included, the Company estimates the amount of variable consideration and handling costsdetermines what portion of that, if any, has a high probability of significant subsequent revenue reversal, and excluding applicable taxes related to sales.

Contractsif so, that amount is excluded from the transaction price. The Company’s contracts with customers frequently contain multiple deliverables,, such as systems, upgrades, components, spare parts, installation, maintenance, and service plans.plans. Judgment is required to properly identify the accounting units of the multiple-element arrangementsperformance obligations within a contract and to determine how the revenue should be allocated among the accounting units. Veecoperformance obligations. The Company also evaluates whether multiple transactions with the same customer or related parties should be considered part of a single multiple-element arrangementcontract based on an assessment of whether the contracts or agreements are negotiated or executed within a short time frame of each other or if there are indicators that the contracts are negotiated in contemplation of one another. Moreover, judgment is used in interpreting the commercial terms and determining when all criteria have been met in order to recognize revenue in the appropriate accounting period.

   

When there are separate units of accounting, Veecothe Company allocates revenue to each elementperformance obligation on a relative stand-alone selling price basis. The stand-alone selling prices are determined based on the following selling price hierarchy: vendor-specific objective evidence (“VSOE”) if available; third party evidence (“TPE”) if VSOE is not available; orprices at which the best estimateCompany separately sells the systems, upgrades, components, spare parts, installation, maintenance, and service plans. For items

8

Table of selling price (“BESP”) if neither VSOE nor TPE is available. Contents

Veeco uses BESP for the elements in its arrangements. The maximum revenue recognized on a delivered element is limitedInstruments Inc. and Subsidiaries

Notes to the amount Consolidated Financial Statements - continued

(unaudited)

that isare not contingent uponsold separately, the delivery of additional items.Company estimates stand-alone selling prices generally using an expected cost plus margin approach.

   

VeecoMost of the Company’s revenue is recognized at a point in time when the performance obligation is satisfied. The Company considers many facts when evaluating each of its sales arrangements to determine the timing of revenue recognition, including its contractual obligations the customer’s creditworthiness, and the nature of the customer’s post-delivery acceptance provisions. Veeco’sThe Company’s system sales arrangements, including certain upgrades, generally include field acceptance provisions that may include functional or mechanical test procedures. For the majoritymany of thethese arrangements, a customer source inspection of the system is performed in Veeco’sthe Company’s facility, or test data is sent to the customer documenting that the system is functioning to the agreed upon specifications prior to delivery.delivery, or other quality assurance testing is performed internally to ensure system functionality prior to shipment. Historically, such source inspection or test data replicates the field acceptance provisions that are performed at the customer’s site prior to final acceptance of the system. When Veecothe Company objectively demonstrates that the criteria specified in the contractual acceptance provisions are achieved prior to delivery either through customer testing or the Company’s historical experience of its tools meeting specifications, transfer of control of the product to the customer is considered to have occurred and revenue is recognized upon system delivery since there is no substantive contingency remaining related to the acceptance provisions at that date, subject to the retention amount constraint described below for certain contracts.date. For new products, new applications of existing products, or for products with substantive customer acceptance provisions where Veecothe Company cannot objectively demonstrate that the criteria specified in the contractual acceptance provisions have been achieved prior to delivery, revenue and the associated costs are deferreddeferred. The Company recognizes such revenue and fully recognizedcosts upon obtaining objective evidence that the receipt of customer acceptance provisions can be achieved, assuming all other revenue recognition criteria have been met.

The Company’s system sales arrangements, including certain upgrades, generally do not contain provisions for the right of return, forfeiture, refund, or other purchase price concession. In the rare instances where such provisions are included, all revenue is deferred until such rights expire. The sales arrangements generally include installation. The installation process is not deemed essential to the functionality of the equipment since it is not complex; it does not require significant changes to the features or capabilities of the equipment or involve constructing elaborate interfaces or connections subsequent to factory acceptance. Veeco has a demonstrated history of consistently completing installations in a timely manner and can reliably estimate the costs of such activities. Most customers engage Veeco to perform the installation services, although there are other third-party providers with sufficient knowledge who could complete these services. Based on these factors, installation is deemed to be inconsequential or perfunctory relative to the system sale as a whole, and as a result, installation service is not considered a separate element of the arrangement. As such, Veeco records the cost of the installation at the earlier of the time of revenue recognition for the system or when installation services are performed.

   

In certain cases Veeco’s products are soldthe Company’s contracts with customers contain a billing retention, typically 10% of the sales price, which is billed by Veecothe Company and payable by the customer when field acceptance provisions are completed. The amountRevenue recognized in advance of revenue recognized upon delivery of a system or upgrade, if any, is limited to the lower of i) the amount that has been billed that is not contingent upon acceptance provisions or ii)recorded as a contract asset on the value of the arrangement consideration allocated to the delivered elements, if such sale is part of a multiple-element arrangement.Consolidated Balance Sheets.

   

The Company recognizes revenue related to maintenance and service contracts ratably over time based upon the applicablerespective contract term. VeecoInstallation revenue is recognized over time as the installation services are performed. The Company recognizes revenue from the sales of components, spare parts, and specified service engagements at a point in time, which is typically consistent with the time of delivery in accordance with the terms of the applicable sales arrangement.

   

The Company may receive customer deposits on system transactions. The timing of the transfer of goods or services related to the deposits is either at the discretion of the customer or expected to be within one year from the deposit receipt. As such, the Company does not adjust transaction prices for the time value of money. Incremental direct costs incurred related to the acquisition of a customer contract, such as sales commissions, are expensed as incurred even ifsince the expected amortization period is one year or less.

The Company has elected to treat shipping and handling costs as a fulfillment activity, and the Company includes such costs in cost of sales when the Company recognizes revenue for the related revenuegoods. Taxes assessed by governmental authorities that are collected by the Company from a customer are excluded from revenue.

Inventories

Inventories are stated at the lower of cost or net realizable value, with cost determined on a first-in, first-out basis. Each quarter the Company assesses the valuation and recoverability of all inventories: materials (raw materials, spare parts, and service inventory); work-in-process; and finished goods. Obsolete inventory or inventory in excess of management’s estimated usage requirement is deferredwritten down to its estimated net realizable value if less than cost. The Company evaluates usage requirements by analyzing historical usage, anticipated demand, alternative uses of materials, and other qualitative factors. Unanticipated changes in accordance with the above policy.

Recent accounting pronouncements

The FASB issued ASU 2014-09, as amended: Revenue from Contracts with Customers, which has been codified as Accounting Standards Codification 606 (“ASC 606”). ASC 606 requiresdemand for the Company’s revenue recognitionproducts may require a write down of

9

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to depict the transferConsolidated Financial Statements - continued

(unaudited)

inventory, which would be reflected in cost of promised goods or services to customerssales in the period the revision is made. Inventory acquired as part of a business combination is recorded at fair value on the date of acquisition.

Recently Adopted Accounting Standards

The Company adopted ASU 2020-06: Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instrumentsand Contracts in an amountEntity’s Own Equity on January 1, 2022, using the modified retrospective method for all financial instruments that reflects the consideration to which it expects to be entitled in exchange for those goods or services. ASC 606 outlines a five-step model to make the revenue recognition determination and requires new financial statement disclosures. Publicly-traded companies are required to adopt ASC 606 for reporting periods beginning after December 15, 2017. The Company is still completing its evaluationoutstanding as of the impact of adopting this standard; however,adoption date. This standard simplifies the Company currently expectsaccounting for convertible debt instruments by removing the most significant financial statement impacts of adopting ASC 606 will be the elimination of the constraint on revenue associatedseparation models for convertible debt with the billing retention related to the receipt of customer final acceptancea cash conversion feature, as well as the identification of installation servicesconvertible instruments with a beneficial conversion feature. As a result, entities will account for a convertible debt instrument wholly as a performance obligation.debt, unless certain other conditions are met. The elimination of these models will reduce non-cash interest expense for entities that have issued a convertible instrument that was within the constraint on revenue related to customer final acceptance, which is usually about 10 percentscope of a system sale, will generally be recognized atthose models before the timeadoption of ASU 2020-06, such as the Company transfers controlCompany’s 2023 Notes, 2025 Notes, and 2027 Notes. Additionally, ASU 2020-06 requires the application of the system to the customer, which is earlier than under the Company’s current revenue recognition model for certain contracts that are subject to the billing retention constraint described above. The new performance obligation related to installation services under the new standard will generally be recognized as the installation services are performed, which is later than under the Company’s current revenue recognition model. Taken together, the Company currently believes there will be a net acceleration of a small percentage of its revenue under ASC 606 as compared to its current revenue recognition model. ASC 606 provides for different transition alternatives, and the Company is evaluating whichif-converted method of adoption to select.

In January 2016, the FASB issued ASU 2016-01: Financial Instruments — Overall, which requires certain equity investments to be measured at fair value, with changes in fair value recognized in net income. Publicly-traded companies are required to adopt the update for reporting periods beginning after December 15, 2017; early adoption is permitted. The Company does not expect this ASU will have a material impact on the consolidated financial statements.

In February 2016, the FASB issued ASU 2016-02: Leases, which generally requires operating lessee rights and obligations to be recognized as assets and liabilities on the balance sheet. In addition, interest on lease liabilities is to be

recognized separately from the amortization of right-of-use assets in the Statement of Operations. Further, payments of the principal portion of lease liabilities are to be classified as financing activities while payments of interest on lease liabilities and variable lease payments are to be classified as operating activities in the Statement of Cash Flows. When the standard is adopted, the Company will be required to recognize and measure leases at the beginning of the earliest period presented using a modified retrospective approach. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018, with early application permitted. The Company is evaluating the anticipated impact of adopting the ASU on the consolidated financial statements.

In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows: Classification of Certain Cash Receipts and Cash Payments, which provides guidance on eight specific cash flow issues, including debt prepayments or debt extinguishment costs. Publicly-traded companies are required to adopt the update for reporting periods beginning after December 15, 2017. This ASU will not have a material impact on the consolidated financial statements.

In October 2016, the FASB issued ASU 2016-16, Income Taxes: Intra-Entity Transfers of Assets Other Than Inventory, which requires that entities recognize the income tax consequences of an intra-entity transfer of an asset, other than inventory, when the transfer occurs. Publicly-traded companies are required to adopt the update for reporting periods beginning after December 15, 2017. This ASU will not have a material impact on the consolidated financial statements.

The Company is also evaluating other pronouncements recently issued but not yet adopted. The adoption of these pronouncements is not expected to have a material impact on our consolidated financial statements.

Note 2 - Income (Loss) Per Common Share

The Company considers unvested share-based awards that have non-forfeitable rights to dividends prior to vesting to be participating shares, which are treated as a separate class of security from the Company’s common shares for calculating per share data. Therefore, the Company applies the two-class method when calculating income (loss) per share. The two-class method is an earnings allocation formula that determinesdiluted earnings per share, for each classand precludes the use of common stock and participating security according to dividends declared and participation rights in undistributed earnings. However, since the holders of the participating shares are not obligated to fund losses, participating shares are excluded from the calculation of loss per share.

The dilutive effect of the Convertible Senior Notes on income (loss) per share is calculated using the treasury stock method sincefor certain debt instruments, such as the Company has bothCompany’s 2023 Notes, 2025 Notes, and 2027 Notes.

The adoption of ASU 2020-06 resulted in the current intentfollowing adjustments to the Consolidated Balance Sheets:

December 31, 2021

Adoption of
ASU 2020-06

January 1, 2022

 (in thousands)

Balance Sheet line item:

Long-term debt

$

229,438

$

44,260

$

273,698

Additional paid-in capital

1,116,921

 

(56,801)

 

1,060,120

Accumulated deficit

(681,283)

 

12,541

 

(668,742)

The adoption of ASU 2020-06 resulted in the following adjustments to the Company’s calculations of basic and ability to settle the principal amount of the Convertible Senior Notes in cash. See Note 5, “Liabilities,” for additional information on the Convertible Senior Notes.

Basicdiluted income (loss) per share is calculated by dividing net income (loss) byfor the weighted average numberthree months ended March 31, 2022:

Three months ended March 31, 2022

    

Under
ASU 2020-06

    

Under legacy accounting

    

Difference

Income per common share:

Basic income per common share

$

0.27

$

0.22

$

0.05

Diluted income per common share

0.24

0.20

0.04

The adoption of shares outstanding duringASU 2020-06 did not materially impact the period underCompany’s cash flows or compliance with debt covenants.

i

10

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to the two-class method. DilutedConsolidated Financial Statements - continued

(unaudited)

Note 2 — Income Per Common Share

Basic income per share is calculated by dividing net income by the weighted average number of shares outstanding during the period. Diluted income per share is calculated by dividing net income available to common shareholders by the weighted average number of shares used to calculate basic income (loss) per share plus the weighted average number of common share equivalents outstanding during the period. The dilutive effect of outstanding options to purchase common stock and non-participating share-based awards is considered in diluted income per share by application of the treasury stock method. The dilutive effect of performance share units is included in diluted income per common share in the periodsif the performance targets have been achieved.achieved, or would have been achieved if the reporting date was the end of the contingency period. Upon the adoption of ASU 2020-06 on January 1, 2022, the Company includes the dilutive effect of shares issuable upon conversion of its Notes in the calculation of diluted income per share using the if-converted method. Prior to the adoption of ASU 2020-06, based on the Company’s ability and intent to settle the principal amount of its convertible senior notes in cash, and the excess of the principal portion in shares of its common stock, the Company accounted for the conversion spread using the treasury stock method, and the shares issuable upon conversion of the Notes were not included in the calculation of diluted earnings per share except to the extent that the conversion value of the Notes exceeds their principal amount and if the effect would be dilutive. The computations of basic and diluted income (loss) per share for the three and nine months ended September 30, 2017 and 2016 are as follows:

 

 

Three months ended September 30,

 

Nine months ended September 30,

 

 

 

2017

 

2016

 

2017

 

2016

 

 

 

(in thousands, except per share amounts)

 

Net income (loss)

 

$

(21,884

)

$

(69,598

)

$

(39,177

)

$

(117,212

)

 

 

 

 

 

 

 

 

 

 

Net income (loss) per common share:

 

 

 

 

 

 

 

 

 

Basic

 

$

(0.47

)

$

(1.78

)

$

(0.91

)

$

(2.99

)

Diluted

 

$

(0.47

)

$

(1.78

)

$

(0.91

)

$

(2.99

)

 

 

 

 

 

 

 

 

 

 

Basic weighted average shares outstanding

 

46,941

 

39,131

 

43,100

 

39,193

 

Effect of potentially dilutive share-based awards

 

 

 

 

 

Diluted weighted average shares outstanding

 

46,941

 

39,131

 

43,100

 

39,193

 

 

 

 

 

 

 

 

 

 

 

Unvested participating shares excluded from basic weighted average shares outstanding since the securityholders are not obligated to fund losses

 

166

 

469

 

166

 

469

 

 

 

 

 

 

 

 

 

 

 

Common share equivalents excluded from the diluted weighted average shares outstanding since Veeco incurred a net loss and their effect would be antidilutive

 

220

 

140

 

275

 

45

 

 

 

 

 

 

 

 

 

 

 

Potentially dilutive non-participating shares excluded from the diluted calculation as their effect would be antidilutive

 

1,956

 

2,030

 

1,628

 

2,042

 

 

 

 

 

 

 

 

 

 

 

Maximum potential shares to be issued for settlement of Convertible Senior Notes excluded from the diluted calculation as their effect would be antidilutive

 

8,618

 

 

8,618

 

 

Note 3 — Business Combinations

Ultratech

On May 26, 2017, the Company completed its acquisition of Ultratech, Inc. (“Ultratech”).  Ultratech designs, manufactures, and markets lithography, laser annealing, and inspection equipment for manufacturers of semiconductor devices, including front-end semiconductor manufacturing and advanced packaging. Ultratech also designs, manufactures, and markets atomic layer deposition (“ALD”) equipment for scientific and industrial applications. Ultratech’s customers are primarily located throughout the United States, EMEA, China, Japan, Taiwan, Singapore, and Korea. With the addition of Ultratech, the Company establishes itself as a leading equipment supplier in the advanced packaging market, forming a strong technology portfolio to address critical advanced packaging applications. The results of Ultratech’s operations have been included in the consolidated financial statements since the date of acquisition.

Ultratech shareholders received (i) $21.75 per share in cash and (ii) 0.2675 of a share of Veeco common stock for each Ultratech common share outstanding on the acquisition date. In connection with the Company’s continued finalization of purchase accounting, during the three months ended September 30, 2017, the Company decreased the fair value of acquired inventory and property, plant and equipment by $4.1 million and $1.2 million, respectively, resulting in a corresponding increase in goodwill. The Company plans to finalize the purchase accounting within the measurement period, which may include additional adjustments to the fair values of assets acquired and liabilities assumed. The preliminary acquisition date fair value of the consideration totaled $633.4 million, net of cash acquired, which consisted of the following:

 

 

Acquisition Date

 

 

 

(May 26, 2017)

 

 

 

(in thousands)

 

Cash consideration, net of cash acquired

 

$

404,489

 

Equity consideration (7.2 million shares issued)

 

228,644

 

Replacement equity awards attributable to pre-acquisition service

 

228

 

Acquisition date fair value

 

$

633,361

 

The following table summarizes the preliminary estimated fair values of the assets acquired and liabilities assumed at the acquisition date:

 

 

Acquisition Date

 

 

 

(May 26, 2017)

 

 

 

(in thousands)

 

Short-term investments

 

$

47,161

 

Accounts receivable

 

45,465

 

Inventory and deferred cost of sales

 

57,570

 

Prepaid expense and other current assets

 

7,217

 

Property, plant, and equipment

 

18,332

 

Intangible assets

 

346,940

 

Other assets

 

6,442

 

Total identifiable assets acquired

 

529,127

 

 

 

 

 

Accounts payable and accrued expenses

 

40,123

 

Customer deposits and deferred revenue

 

4,834

 

Deferred income taxes

 

32,478

 

Other liabilities

 

11,952

 

Total liabilities assumed

 

89,387

 

 

 

 

 

Net identifiable assets acquired

 

439,740

 

Goodwill

 

193,621

 

Net assets acquired

 

$

 633,361

 

The gross contractual value of the acquired accounts receivable was approximately $46.0 million. The fair value of the accounts receivables is the amount expected to be collected by the Company. Goodwill generated from the acquisition is primarily attributable to expected synergies from future growth and strategic advantages provided through the expansion of product offerings as well as assembled workforce and is not expected to be deductible for income tax purposes.

The preliminary classes of intangible assets acquired and the estimated useful life of each class is presented in the table below:

 

 

Acquisition Date

 

 

 

(May 26, 2017)

 

 

 

Amount

 

Useful life

 

 

 

(in thousands)

 

 

 

Technology

 

$

158,390

 

8 years

 

Customer relationships

 

116,710

 

12 years

 

Backlog

 

3,080

 

6 months

 

In-process research and development

 

43,340

 

*

 

Trademark and tradenames

 

25,420

 

7 years

 

Intangible assets acquired

 

$

346,940

 

 

 


*In-process research and development will be amortized (or impaired) upon completion (or abandonment) of the development project.

The Company determined the estimated fair value of the identifiable intangible assets based on various factors including: cost, discounted cash flow, income method, loss-of-revenue/income method, and relief-from-royalty method in determining the purchase price allocation.

In-process research and development (“IPR&D”) represents the estimated fair values of incomplete Ultratech research and development projects that had not reached the commercialization stage and meet the criteria for recognition as IPR&D as of the date of the acquisition. In the future, the fair value of each project at the acquisition date will be either amortized or impaired depending on whether the projects are completed or abandoned. The fair value of IPR&D was determined using an income approach and costs to complete the project and expected commercialization timelines are considered key assumptions. This valuation approach reflects the present value of the projected cash flows that are expected to be generated by the IPR&D less charges representing the contribution of other assets to those cash flows. The value of the IPR&D was determined to be $43.3 million, approximately half of which is related to Ultratech’s lithography technologies and one-third of which is related to Ultratech’s laser annealing technologies.

For the three and nine months ended September 30, 2017, acquisition related costs were approximately $0.8 million and $16.3 million, respectively, including non-cash charges of $4.2 million for the nine months ended September 30, 2017 related to accelerated share-based compensation for employee terminations.

The amounts of revenue and income (loss) from operations before income taxes of Ultratech included in the Company’s consolidated statement of operations for the three and nine months ended September 30, 2017 are as follows:

 

 

Three months ended
September 30, 2017

 

Nine months ended
September 30, 2017

 

 

 

(in thousands)

 

Revenue

 

$

21,236

 

$

45,286

 

Loss from operations before income taxes

 

$

(21,556

)

$

(44,374

)

Loss from operations before income taxes of Ultratech for the three month period ended September 30, 2017 of $21.6 million includes acquisition costs of $0.8 million, release of inventory fair value step-up related to purchase accounting of $1.9 million, amortization expense on intangible assets of $9.6 million, and restructuring charges of $2.1 million. Loss from operations before income taxes of Ultratech for the nine month period ended September 30, 2017 of $44.4 million includes acquisition costs of $16.3 million, release of inventory fair value step-up related to purchase accounting of $9.2 million, amortization expense on intangible assets of $13.1 million, and restructuring charges of $3.3 million.

The following table presents unaudited pro forma financial information as if the acquisition of Ultratech had occurred on January 1, 2016:

 

 

Three months ended September 30,

 

Nine months ended September 30,

 

 

 

2017

 

2016

 

2017

 

2016

 

 

 

(in thousands, except per share amounts)

 

Revenue

 

$

131,872

 

$

134,093

 

$

412,066

 

$

381,586

 

Loss from operations

 

(14,957

)

(74,197

)

(45,309

)

(187,499

)

Diluted earnings per share

 

$

(0.40

)

$

(1.67

)

$

(1.01

)

$

(4.34

)

The pro-forma results were calculated by combining the unaudited results of the Company with the stand-alone unaudited results of Ultratech for the pre-acquisition period, and adjusting for the following:

(i)                                   Additional amortization expense related to identified intangibles valued as part of the purchase price allocation that would have been incurred starting on January 1, 2016.

(ii)                                Additional depreciation expense for the property, plant, and equipment fair value adjustments that would have been incurred starting on January 1, 2016.

(iii)                             All acquisition related costs incurred by the Company as well as by Ultratech pre-acquisition have been removed from their respective periods and included in the three months ended March 31, 2016,2022 and 2021 are as such expenses would have been incurred in the first quarter following the acquisition.

(iv)                            All amortization of inventory step-up has been removed from their respective periods and recorded in the first two quarters of 2016, as such costs would have been incurred as the corresponding inventory was sold.follows:

Three months ended March 31,

    

2022

    

2021

    

(in thousands, except per share amounts)

Numerator:

Net income

$

13,330

$

2,494

Interest expense associated with convertible notes

2,544

Net income available to common shareholders

$

15,874

$

2,494

Denominator:

Basic weighted average shares outstanding

 

49,614

 

48,624

Effect of potentially dilutive share-based awards

1,208

1,494

Dilutive effect of convertible notes

 

14,463

 

2,932

Diluted weighted average shares outstanding

 

65,285

 

53,050

Net income per common share:

Basic

$

0.27

$

0.05

Diluted

$

0.24

$

0.05

Potentially dilutive shares excluded from the diluted calculation as their effect would be antidilutive

613

878

Maximum potential shares to be issued for settlement of the convertible notes excluded from the diluted calculation as their effect would be antidilutive

504

8,811

(v)                               Additional interest expense related to the Convertible Senior Notes (see Note 5, “Liabilities”) as if they had been issued on January 1, 2016.

(vi)                            Income tax expense (benefit) was adjusted for the impact of the above adjustments for each period.

Note 4 -3 — Assets

Investments

Short-term investments are generally classified as available-for-sale and reported at fair value, with unrealized gains and losses, net of tax, presented as a separate component of stockholders’ equity under the caption “Accumulated other comprehensive income” in the Consolidated Balance Sheets. These securities may include U.S. treasuries, government agency securities, corporate debt, and commercial paper, all with maturities of greater than three months when acquired.purchased. All realized gains and losses and unrealized losses resulting from declines in fair value that are other than temporary are included in “Other operating expense (income), net” in the Consolidated Statements of Operations.

11

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

Fair value is the price that would be received for an asset or the amount paid to transfer a liability in an orderly transaction between market participants. Veeco classifies certain assets based on the following fair value hierarchy:

Level 1: Quoted prices in active markets that are unadjusted and accessible at the measurement date for identical, unrestricted assets or liabilities;

Level 2: Quoted prices for identical assets and liabilities in markets that are not active, quoted prices for similar assets and liabilities in active markets or financial instruments for which significant inputs are observable, either directly or indirectly; and

Level 3: Prices or valuations that require inputs that are both significant to the fair value measurement and unobservable.

A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Veeco has evaluated the estimated fair value of financial instruments using available market information and valuations as provided by third-party sources. The use of different market assumptions and/or estimation methodologies could have a significant effect on the estimated fair value amounts.

The following table presents the portion of Veeco’s assets that were measured at fair value on a recurring basis at September 30, 2017March 31, 2022 and December 31, 2016:2021:

 

 

Level 1

 

Level 2

 

Level 3

 

Total

 

 

 

(in thousands)

 

September 30, 2017

 

 

 

 

 

 

 

 

 

Cash equivalents

 

 

 

 

 

 

 

 

 

Corporate debt

 

$

 

$

1,500

 

$

 

$

1,500

 

Total

 

$

 

$

1,500

 

$

 

$

1,500

 

Short-term investments

 

 

 

 

 

 

 

 

 

U.S. treasuries

 

$

58,806

 

$

 

$

 

$

58,806

 

Corporate debt

 

 

10,911

 

 

10,911

 

Commercial paper

 

 

16,136

 

 

16,136

 

Total

 

$

58,806

 

$

27,047

 

$

 

$

85,853

 

 

 

 

 

 

 

 

 

 

 

December 31, 2016

 

 

 

 

 

 

 

 

 

Cash equivalents

 

 

 

 

 

 

 

 

 

Corporate debt

 

$

 

$

1,501

 

$

 

$

1,501

 

Total

 

$

 

$

1,501

 

$

 

$

1,501

 

Short-term investments

 

 

 

 

 

 

 

 

 

U.S. treasuries

 

$

40,008

 

$

 

$

 

$

40,008

 

Government agency securities

 

 

10,012

 

 

10,012

 

Corporate debt

 

 

13,773

 

 

13,773

 

Commercial paper

 

 

2,994

 

 

2,994

 

Total

 

$

40,008

 

$

26,779

 

$

 

$

66,787

 

    

Level 1

    

Level 2

    

Level 3

    

Total

(in thousands)

March 31, 2022

Cash equivalents

Certificate of deposits and time deposits

$

53,116

$

$

$

53,116

Money market cash

208

208

Total

$

53,324

$

$

$

53,324

Short-term investments

U.S. treasuries

$

52,147

$

$

$

52,147

Government agency securities

10,484

10,484

Corporate debt

39,646

39,646

Commercial paper

1,000

1,000

Total

$

52,147

$

51,130

$

$

103,277

December 31, 2021

Cash equivalents

Certificate of deposits and time deposits

$

41,544

$

$

$

41,544

Money market cash

121

121

Total

$

41,665

$

$

$

41,665

Short-term investments

U.S. treasuries

$

51,095

$

$

$

51,095

Government agency securities

12,052

12,052

Corporate debt

40,035

40,035

Commercial paper

999

999

Total

$

51,095

$

53,086

$

$

104,181

There were no 0 transfersbetweenfair value measurement levels during the three and nine months ended September 30, 2017.March 31, 2022.

12

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

At September 30, 2017March 31, 2022 and December 31, 2016,2021, the amortized cost and fair value of available-for-sale securities consist of:

    

    

Gross

    

Gross

    

Amortized

Unrealized

Unrealized

Estimated

Cost

Gains

Losses

Fair Value

 

 

 

Gross

 

Gross

 

 

 

 

Amortized

 

Unrealized

 

Unrealized

 

Estimated

 

 

Cost

 

Gains

 

Losses

 

Fair Value

 

 

(in thousands)

 

September 30, 2017

 

 

 

 

 

 

 

 

 

U.S. treasuries

 

$

58,816

 

$

3

 

$

(13

)

$

58,806

 

Corporate debt

 

10,912

 

1

 

(2

)

10,911

 

Commercial paper

 

16,135

 

1

 

 

16,136

 

Total

 

$

85,863

 

$

5

 

$

(15

)

$

85,853

 

 

 

 

 

 

 

 

 

 

December 31, 2016

 

 

 

 

 

 

 

 

 

(in thousands)

March 31, 2022

U.S. treasuries

 

$

40,013

 

$

 

$

(5

)

$

40,008

 

$

52,737

$

$

(590)

$

52,147

Government agency securities

 

10,020

 

 

(8

)

10,012

 

10,564

(80)

10,484

Corporate debt

 

13,780

 

 

(7

)

13,773

 

40,126

(480)

39,646

Commercial paper

 

2,994

 

 

 

2,994

 

1,000

1,000

Total

 

$

66,807

 

$

 

$

(20

)

$

66,787

 

$

104,427

$

$

(1,150)

$

103,277

December 31, 2021

U.S. treasuries

$

51,269

$

$

(174)

$

51,095

Government agency securities

12,075

(23)

12,052

Corporate debt

 

40,169

(134)

 

40,035

Commercial paper

999

999

Total

$

104,512

$

$

(331)

$

104,181

Available-for-sale securities in a loss position at September 30, 2017March 31, 2022 and December 31, 20162021 consist of:

 

 

September 30, 2017

 

December 31, 2016

 

 

 

 

 

Gross

 

 

 

Gross

 

 

 

Estimated

 

Unrealized

 

Estimated

 

Unrealized

 

 

 

Fair Value

 

Losses

 

Fair Value

 

Losses

 

 

 

(in thousands)

 

U.S. treasuries

 

$

41,864

 

$

(13

)

$

20,002

 

$

(5

)

Government agency securities

 

 

 

10,012

 

(8

)

Corporate debt

 

7,909

 

(2

)

13,774

 

(7

)

Total

 

$

49,773

 

$

(15

)

$

43,788

 

$

(20

)

March 31, 2022

December 31, 2021

    

    

Gross

    

    

Gross

Estimated

Unrealized

Estimated

Unrealized

Fair Value

Losses

Fair Value

Losses

(in thousands)

U.S. treasuries

$

52,147

$

(590)

$

51,095

$

(174)

Government agency securities

10,484

(80)

12,052

(23)

Corporate debt

 

39,646

 

(480)

 

40,035

 

(134)

Total

$

102,277

$

(1,150)

$

103,182

$

(331)

At September 30, 2017March 31, 2022 and December 31, 2016,2021, there were no0 short-term investments that had been in a continuous loss position for more than 12 months.

The contractual maturities of securities classified as available-for-sale securities at September 30, 2017 all contractually mature in one year or less. March 31, 2022 were as follows:

March 31, 2022

Amortized

Estimated

Cost

Fair Value

(in thousands)

Due in one year or less

$

77,493

$

76,943

Due after one year through two years

26,934

 

26,334

Total

$

104,427

$

103,277

Actual maturities may differ from contractual maturities. Veeco may sell these securities prior to maturity based on the needs of the business. In addition,maturities because borrowers may have the right to call or prepay obligations prior to scheduled maturities.

with or without call or prepayment penalties. There were minimal0 realized gains or losses for the three and nine months ended September 30, 2017March 31, 2022 and no realized gains for2021.

13

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to the three and nine months ended September 30, 2016. The cost of securities liquidated is based on specific identification.Consolidated Financial Statements - continued

(unaudited)

Accounts receivableReceivable

Accounts receivable is presented net of an allowance for doubtful accounts of $0.3$0.7 million at September 30, 2017March 31, 2022 and December 31, 2016.2021. The Company considered its current expectations of future economic conditions, including the impact of COVID-19, when estimating its allowance for doubtful accounts.

Inventories

Inventories are stated at the lower of cost or net realizable value, with cost determined on a first-in, first-out basis. Inventories at September 30, 2017March 31, 2022 and December 31, 20162021 consist of the following:following:

March 31,

December 31,

    

2022

    

2021

 

September 30,

 

December 31,

 

 

2017

 

2016

 

 

(in thousands)

 

(in thousands)

Materials

 

$

59,767

 

$

46,457

 

$

102,296

$

96,027

Work-in-process

 

37,884

 

25,250

 

 

60,820

 

54,128

Finished goods

 

16,030

 

5,356

 

 

15,950

 

20,703

Total

 

$

113,681

 

$

77,063

 

$

179,066

$

170,858

Prepaid expensesExpenses and other current assetsOther Current Assets

Prepaid expenses and other current assets primarily consist of supplier deposits, prepaid value-added tax, lease deposits, prepaid insurance, prepaid licenses, and prepaid licenses.other receivables. The balance as of March 31, 2022 includes a current receivable of $15.0 million for insurance recoveries related to the legal settlement referenced in Note 5, “Commitments and Contingencies.” In addition, Veeco had deposits with its suppliers of $6.7$8.4 million and $7.8$3.9 million at September 30, 2017March 31, 2022 and December 31, 2016,2021, respectively. Additionally, included within prepaid expenses and other current assets at September 30, 2017 was a non-trade receivable of approximately $12.8 million.

Property, plant,Plant, and equipmentEquipment

Property, plant, and equipment at September 30, 2017March 31, 2022 and December 31, 20162021 consist of the following:

 

 

September 30,

 

December 31,

 

 

 

2017

 

2016

 

 

 

(in thousands)

 

Land

 

$

5,669

 

$

5,669

 

Building and improvements

 

50,367

 

50,814

 

Machinery and equipment(1)

 

126,631

 

99,370

 

Leasehold improvements

 

10,471

 

3,652

 

Gross property, plant and equipment

 

193,138

 

159,505

 

Less: accumulated depreciation and amortization

 

108,735

 

98,859

 

Net property, plant, and equipment

 

$

84,403

 

$

60,646

 


March 31,

December 31,

    

2022

    

2021

(in thousands)

Land

$

5,061

$

5,061

Building and improvements

 

63,973

 

63,946

Machinery and equipment (1)

 

149,192

 

145,656

Leasehold improvements

 

50,534

 

45,979

Gross property, plant, and equipment

 

268,760

 

260,642

Less: accumulated depreciation and amortization

 

164,632

 

160,899

Net property, plant, and equipment

$

104,128

$

99,743

(1)Machinery and equipment also includes software, furniture and fixtures

(1) Machinery and equipment also includes software, furniture and fixtures

For the three and nine months ended September 30, 2017,March 31, 2022 and 2021, depreciation expense was $4.2$3.7 million and $10.6 million, respectively, and $3.5 million, and $10.2 million for the comparable 2016 periods.respectively.

Goodwill

Goodwill represents the future economic benefits arising from assets acquired in a business combination that are not individually identified and separately recognized. The following table presentsCompany continues to assess potential triggering events related to the changes invalue of its goodwill balances forand concluded that there were no indicators of impairment during the ninethree months ended September 30, 2017:March 31, 2022.

 

 

Gross carrying

 

Accumulated

 

 

 

 

 

amount

 

impairment

 

Net amount

 

 

 

(in thousands)

 

Balance at December 31, 2016

 

$

238,108

 

$

123,200

 

$

114,908

 

Acquisition

 

193,621

 

 

193,621

 

Balance at September 30, 2017

 

$

431,729

 

$

123,200

 

$

308,529

 

14

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

Intangible assetsAssets

Intangible assets consist of purchased technology, customer-related intangible assets, in-process researchcustomer relationships, patents, trademarks and development, trademarks (both long-livedtradenames, and indefinite-lived), patents, backlog, and licenses and are initially recorded at fair value. Long-lived intangiblesintangible assets are amortized over their estimated useful lives in a method reflecting the pattern in which the economic benefits are consumed or amortized on a straight-line basis if such pattern cannot be reliably determined. The Company continues to assess potential triggering events related to the value of its intangible assets and concluded that there were no indicators of impairment during the three months ended March 31, 2022.

The components of purchased intangible assets were as follows:

 

 

 

 

September 30, 2017

 

December 31, 2016

 

 

 

Weighted

 

 

 

Accumulated

 

 

 

 

 

Accumulated

 

 

 

 

 

Average Remaining

 

Gross

 

Amortization

 

 

 

Gross

 

Amortization

 

 

 

 

 

Amortization

 

Carrying

 

and

 

Net

 

Carrying

 

and

 

Net

 

 

 

Period

 

Amount

 

Impairment

 

Amount

 

Amount

 

Impairment

 

Amount

 

 

 

(in years)

 

(in thousands)

 

Technology

 

7.5

 

$

307,588

 

$

125,154

 

$

182,434

 

$

149,198

 

$

113,904

 

$

35,294

 

Customer relationships

 

11.6

 

164,595

 

35,653

 

128,942

 

47,885

 

28,659

 

19,226

 

In-process R&D

 

 

43,340

 

 

43,340

 

 

 

 

Trademarks and tradenames

 

6.6

 

28,010

 

3,272

 

24,738

 

2,590

 

1,948

 

642

 

Indefinite-lived trademark

 

 

2,900

 

 

2,900

 

2,900

 

 

2,900

 

Other

 

0.5

 

3,686

 

2,444

 

1,242

 

2,026

 

1,710

 

316

 

Total

 

9.0

 

$

550,119

 

$

166,523

 

$

383,596

 

$

204,599

 

$

146,221

 

$

58,378

 

March 31, 2022

December 31, 2021

Accumulated

Accumulated

    

Gross

    

Amortization

    

    

Gross

    

Amortization

    

Carrying

and

Net

Carrying

and

Net

Amount

Impairment

Amount

Amount

Impairment

Amount

(in thousands)

Technology

$

327,908

$

312,142

$

15,766

$

327,908

$

310,551

$

17,357

Customer relationships

146,465

133,581

12,884

146,465

132,970

13,495

Trademarks and tradenames

30,910

28,159

2,751

30,910

27,857

3,053

Other

 

3,686

 

3,686

 

 

3,686

 

3,686

 

Total

$

508,969

$

477,568

$

31,401

$

508,969

$

475,064

$

33,905

Other intangible assets primarily consist of patents, backlog,licenses, and licenses.backlog.

Note 4 — Liabilities

Accrued Expenses and Other assetsCurrent Liabilities

Veeco has an ownership interest of less than 20% in a non-marketable investment, Kateeva, Inc. (“Kateeva”). Veeco does not exert significant influence over Kateeva and therefore the investment is carried at cost. There was no change to the $21.0 million carrying value of the investment during the nine months ended September 30, 2017. The investment is included in “Other assets” on the Consolidated Balance Sheets. The investment is subject to a periodic impairment review; as there are no open-market valuations, the impairment analysis requires judgment. The analysis includes assessments of Kateeva’s financial condition, the business outlook for its products and technology, its projected results and cash flow, business valuation indications from recent rounds of financing, the likelihood of obtaining subsequent rounds of financing, and the impact of equity preferences held by Veeco relative to other investors. Fair value of the investment is not estimated unless there are identified events or changes in circumstances that could have a significant adverse effect on the fair value of the investment. No such events or circumstances are present.

Also included within Other assets at September 30, 2017 are deferred compensation plan assets of approximately $3.3 million representing the cash surrender value of life insurance policies held by the Company related to an executive non-qualified deferred compensation plan that was assumed from Ultratech that allows qualifying executives to defer cash compensation. The related plan liability of approximately $4.5 million is included in “Other liabilities” on the Consolidated Balance Sheet.

Note 5 - Liabilities

Accrued expenses and other current liabilities

The components of accrued expenses and other current liabilities at September 30, 2017March 31, 2022 and December 31, 20162021 consist of:

March 31,

December 31,

    

2022

    

2021

 

September 30,

 

December 31,

 

 

2017

 

2016

 

 

(in thousands)

 

(in thousands)

Payroll and related benefits

 

$

27,816

 

$

18,780

 

$

35,427

$

35,712

Merger consideration payable

 

17,844

 

 

Warranty

 

6,555

 

4,217

 

8,207

7,878

Operating lease liabilities

4,376

4,437

Interest

2,744

2,757

Professional fees

 

3,349

 

1,827

 

2,299

1,467

Installation

 

1,418

 

1,382

 

Legal settlement

15,000

15,000

Sales, use, and other taxes

 

1,961

 

1,282

 

 

3,975

 

4,889

Restructuring liability

 

1,893

 

1,796

 

Interest

 

2,307

 

 

Other

 

2,585

 

3,917

 

 

8,892

 

7,612

Total

 

$

65,728

 

$

33,201

 

$

80,920

$

79,752

Warranty

Warranties are typically valid for one year from the date of system final acceptance, and Veecoacceptance. The Company estimates the costs that may be incurred under the warranty. Estimated warranty costswhich are determined by analyzing specific product and historical configuration statistics and regional warranty support costs and are affected by product failure rates, material usage, and labor costs incurred in correcting product failures during the warranty period. Unforeseen component failures or exceptional

15

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

component performance can also result in changes to warranty costs. Changes in product warranty reserves for the ninethree months ended September 30, 2017March 31, 2022 include:

 

 

(in thousands)

 

Balance - December 31, 2016

 

$

4,217

 

Warranties issued

 

4,314

 

Addition from Ultratech acquisition

 

1,889

 

Consumption of reserves

 

(4,741

)

Changes in estimate

 

876

 

Balance - September 30, 2017

 

$

6,555

 

(in thousands)

Balance - December 31, 2021

$

7,878

Warranties issued

 

1,793

Consumption of reserves

 

(1,584)

Changes in estimate

 

120

Balance - March 31, 2022

$

8,207

Restructuring accrualsCustomer Deposits and Deferred Revenue

During 2016, the Company undertook restructuring activities as part of its initiative to streamline operations, enhance efficiencies, and reduce costs, as well as reducing future investments in certain technology development, which together impacted approximately 75 employees. In addition, during 2017, the Company began the acquisition integration process to enhance efficiencies, resulting in additional employee terminations and other facility closing costs. Over the next few quarters, the Company expects to incur additional restructuring costs of $1 million to $5 million as it finalizes all of these activities.

 

 

Personnel

 

 

 

 

 

 

 

Severance and

 

Facility

 

 

 

 

 

Related Costs

 

Closing Costs

 

Total

 

 

 

(in thousands)

 

Balance - December 31, 2016

 

$

1,796

 

$

 

$

1,796

 

Provision

 

3,628

 

4,269

 

7,897

 

Payments

 

(3,531

)

(4,269

)

(7,800

)

Balance - September 30, 2017

 

$

1,893

 

$

 

$

1,893

 

Included within restructuring expense in the Consolidated Statements of Operations for the nine months ended September 30, 2017 is approximately $1.7 million of non-cash charges related to accelerated share-based compensation for employee terminations.

Customer deposits

Customer deposits totaled $27.6$46.4 million and $22.2$46.9 million at September 30, 2017March 31, 2022 and December 31, 2016,2021, respectively. Deferred revenue represents amounts billed, other than deposits, in excess of the revenue that can be recognized on a particular contract at the balance sheet date. Changes in deferred revenue were as follows:

(in thousands)

Balance - December 31, 2021

 

$

16,276

Deferral of revenue

 

2,386

Recognition of unearned revenue

 

(3,170)

Balance - March 31, 2022

 

$

15,492

Mortgage Payable

At DecemberAs of March 31, 2016,2022, the Company had a mortgage note payable associatedhas approximately $17.1 million of remaining performance obligations on contracts with its property in St. Paul, Minnesota,an original estimated duration of one year or more, of which during the third quarter of 2017 was fully extinguished in connectionapproximately 92% is expected to be recognized within one year, with the sale of the building.  The carrying value of the property exceeded the carrying value of the mortgage note of $1.2 million at December 31, 2016. The annual interest rate on the note was 7.91%remaining amounts expected to be recognized between one to three years. The Company determined the mortgage was a Level 3 liability in the fair-value hierarchy and, using a discounted cash flow model, estimated its fair value as $1.2 million at December 31, 2016.has elected to exclude disclosures regarding remaining performance obligations that have an original expected duration of one year or less.

Convertible Senior Notes

2023 Notes

On January 10, 2017, the Company issued $345.0 million of 2.70% convertible senior unsecured notes due 2023 (the “Convertible Senior“2023 Notes”). The Company received net proceeds, after deducting underwriting discounts and fees and expenses payable by the Company, of approximately $335.8 million. The Convertible Senior2023 Notes bear interest at a rate of 2.70% per year, payable semiannually in arrears on January 15 and July 15 of each year, commencing on July 15, 2017. The Convertible Senior2023 Notes mature on January 15, 2023, unless earlier purchased by the Company, redeemed, or converted.

On May 18, 2020, in connection with the completion of a private offering of $125.0 million aggregate principal amount of 3.75% convertible senior notes due 2027 described below, the Company repurchased and retired approximately $88.3 million in aggregate principal amount of its outstanding 2023 Notes, with a carrying amount of $78.1 million, for approximately $81.2 million of cash.

Additionally, on November 11, 2020, the Company entered into a privately negotiated exchange agreement with a holder of its outstanding 2023 Notes, under which the Company agreed to retire $125.0 million in aggregate original principal amount of the 2023 Notes, with a carrying amount of $113.1 million, in exchange for the issuance of $132.5 million in

16

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

aggregate principal amount of new 3.50% convertible senior notes due 2025 described below, which had a fair value that approximated the principal amount of notes issued.

Finally, on November 5, 2021, the Company entered into a privately negotiated note purchase agreement with a holder of its outstanding 2023 Notes, under which the Company agreed to repurchase and retire approximately $111.5 million in aggregate original principal amount of the 2023 Notes, with a carrying amount of $105.5 million, for cash consideration of approximately $115.6 million, and approximately $1.0 million of accrued and unpaid interest.

2025 Notes

On November 17, 2020, as part of the privately negotiated exchange agreement described above, the Company issued $132.5 million of 3.50% convertible senior notes due 2025 (the “2025 Notes”). The 2025 Notes bear interest at a rate of 3.50% per year, payable semiannually in arrears on January 15 and July 15 of each year, commencing on July 15, 2021. The 2025 Notes mature on January 15, 2025, unless earlier purchased by the Company, redeemed, or converted.

2027 Notes

On May 18, 2020, the Company completed a private offering of $125.0 million of 3.75% convertible senior notes due 2027 (the “2027 Notes”). The Company received net proceeds of approximately $121.9 million, after deducting underwriting discounts and fees and expenses payable by the Company. Additionally, the Company used approximately $10.3 million of cash to purchase capped calls, discussed below. The 2027 Notes bear interest at a rate of 3.75% per year, payable semiannually in arrears on June 1 and December 1 of each year, commencing on December 1, 2020. The 2027 Notes mature on June 1, 2027, unless earlier purchased by the Company, redeemed, or converted.

The Convertible Senior2023 Notes, 2025 Notes, and 2027 Notes (collectively, the “Notes”) are unsecured obligations of Veeco and rank senior in right of payment to any of Veeco’s subordinated indebtedness; equal in right of payment to all of Veeco’s unsecured indebtedness that is not subordinated;

effectively subordinated in right of payment to any of Veeco’s secured indebtedness to the extent of the value of the assets securing such indebtedness; and structurally subordinated to all indebtedness and other liabilities (including trade payables) of Veeco’s subsidiaries.

The Convertible Senior Notes are convertible into cash, sharesat the option of the Company’s common stock, or a combination thereof, at the Company’s election,holders upon the satisfaction of specified conditions and during certain periods as described below. The initial conversion rate isrates are 24.9800, 41.6667, and 71.5372 shares of the Company’s common stock per $1,000 principal amount of Convertible Seniorthe 2023 Notes, 2025 Notes, and 2027 Notes, respectively, representing an initial effective conversion priceprices of $40.03, $24.00, and $13.98 per share of common stock.stock, respectively. The conversion raterates may be subject to adjustment upon the occurrence of certain specified events as provided in the indenture governing the Convertible Senior Notes, dated January 18, 2017 between the Company and U.S. Bank National Association, as trustee (the “Indenture”), but will not be adjusted for accrued but unpaid interest.events.

Holders may convert all or any portion of their notes, in multiples of one1 thousand dollar principal amount, at their option at any time prior to the close of business on the business day immediately preceding October 15, 2022 with respect to the 2023 Notes, October 15, 2024 with respect to the 2025 Notes, and October 1, 2026 with respect to the 2027 Notes, only under the following circumstances:

(i)
(i)During any calendar quarter (and only during such calendar quarter), if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day;

(ii)During the 5 consecutive business day period after any five consecutive trading day period (the “measurement period”) in which the trading price per 1 thousand dollar principal amount of Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of Veeco’s common stock and the conversion rate on each such trading day;

17

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

(iii)If the Company calls any or all of applicable series of the Notes for redemption at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or

(iv)Upon the occurrence of specified corporate events.

For the calendar quarter ended March 31, 2022, the last reported sales price of common stock during the 30 consecutive trading days, based on the criteria outlined in (i) above, was greater than 130% of the conversion price on each applicable trading day;

(ii)                     During the five consecutive business day period after any five consecutive trading day period (the “measurement period”) in which the trading price per one thousand dollar principal amount of Convertible Senior Notes for each trading day of the measurement period was less than 98% of2027 Notes, and as such the product of2027 Notes are convertible by the last reported sale price of Veeco’s common stock and the conversion rate on each such trading day;holders until June 30, 2022.

(iii)                  If the Company calls any or all of the Convertible Senior Notes for redemptionHolders may convert their notes at any time, prior toregardless of the close of businessforegoing circumstances, on the scheduled trading day immediately preceding the redemption date; or

(iv)                Upon the occurrence of specified corporate events.

On or after October 15, 2022 with respect to the 2023 Notes, October 15, 2024 with respect to the 2025 Notes, and October 1, 2026 with respect to the 2027 Notes, until the close of business on the business day immediately preceding the Maturity Date, holders may convert their notes at any time, regardlessrespective maturity date.

Accounting for the Notes after the adoption of ASU 2020-06

The Company adopted ASU 2020-06 on January 1, 2022 as further described in Note 1,Basis of Presentation”. Following the adoption of ASU 2020-06, the Notes are recorded as a single unit within liabilities in the consolidated balance sheets as the conversion features within the Notes are not derivatives that require bifurcation and the Notes do not involve a substantial premium. Transaction costs of $9.2 million, $1.9 million, and $3.1 million incurred in connection with the issuance of the foregoing circumstances.2023 Notes, 2025 Notes, and 2027 Notes, respectively, were recorded as direct deductions from the related debt liabilities and recognized as non-cash interest expense using the effective interest method over the expected terms of the Notes.

Accounting for the Notes prior to the adoption of ASU 2020-06

Upon conversion by the holders, the Company may elect to settle such conversion in shares of its common stock, cash, or a combination thereof. As a result of its cash conversion option,options, prior to the adoption of ASU 2020-06, the Company segregated the liability component of the instrumentinstruments from the equity component.components. The liability component wascomponents were measured by estimating the fair value of a non-convertible debt instrument that is similar in its terms to the Convertible Senior Notes. The calculation of the fair value of the debt componentcomponents required the use of Level 3 inputs, including utilization of convertible investors’ credit assumptions and high yield bond indices. Fair value was estimated through discounting future interest and principal payments, an income approach, due under the Convertible Senior Notes at a discount rate of 7.00%, an interest rate equal to the estimated borrowing rate for similar non-convertible debt.debt, or 7.0%, 8.0%, and 9.1% with respect to the 2023 Notes, 2025 Notes, and 2027 Notes, respectively. The excess of the aggregate face valuevalues of the Convertible Senior Notes over the estimated fair valuevalues of the liability componentcomponents of $72.5 million, was$21.0 million, and $34.2 million with respect to the 2023 Notes, 2025 Notes, and 2027 Notes, respectively, were recognized as a debt discountdiscounts and recorded as an increase to additional paid-in capital and willwere to be amortized over the expected lifelives of the Convertible Senior Notes using the effective interest rate method. Amortization of the debt discount isdiscounts were recognized as non-cash interest expense.

The transaction costs of $9.2 million, $1.9 million, and $3.1 million incurred in connection with the issuance of the Convertible Senior2023 Notes, 2025 Notes, and 2027 Notes, respectively, were allocated to the liability and equity components based on their relative values. Transaction costs allocated to the liability component arewere being amortized using the effective interest rate method and recognized as non-cash interest expense over the expected termterms of the Convertible Senior Notes. Transaction costs allocated to the equity component of $1.9 million, $0.3 million, and $0.8 million with respect to the 2023 Notes, 2025 Notes, and 2027 Notes, respectively, reduced the value of the equity componentcomponents recognized in stockholders’stockholders' equity.

18

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

The carrying value of the Convertible Senior2023 Notes, is2025 Notes and 2027 Notes are as follows:

 

 

September 30,

 

 

 

2017

 

 

 

(in thousands)

 

Principal amount

 

$

345,000

 

Unamortized debt discount

 

(65,570

)

Unamortized transaction costs

 

(6,605

)

Net carrying value

 

$

272,825

 

March 31, 2022

December 31, 2021

  

Principal Amount

  

Unamortized
transaction costs

  

Net carrying value

  

Principal Amount

  

Unamortized
debt discount/
transaction costs

  

Net carrying value

(in thousands)

2023 Notes

$

20,173

$

(77)

$

20,096

$

20,173

$

(967)

$

19,206

2025 Notes

 

132,500

 

(1,334)

 

131,166

 

132,500

 

(17,302)

 

115,198

2027 Notes

125,000

(2,326)

122,674

125,000

(29,966)

95,034

Net carrying value

$

277,673

$

(3,737)

$

273,936

$

277,673

$

(48,235)

$

229,438

Total interest expense related to the Convertible Senior2023 Notes, 2025 Notes and 2027 Notes is as follows:

 

 

Three months ended
September 30,

 

Nine months ended
September 30,

 

 

 

2017

 

2017

 

 

 

(in thousands)

 

Cash Interest Expense

 

 

 

 

 

Coupon interest expense

 

$

2,329

 

$

6,573

 

Non-Cash Interest Expense

 

 

 

 

 

Amortization of debt discount

 

2,502

 

6,942

 

Amortization of transaction costs

 

252

 

699

 

Total Interest Expense

 

$

5,083

 

$

14,214

 

Three months ended March 31,

    

2022

    

2021

    

 

(in thousands)

Cash Interest Expense

 

  

  

Coupon interest expense - 2023 Notes

$

136

$

889

Coupon interest expense - 2025 Notes

1,159

1,159

Coupon interest expense - 2027 Notes

1,172

1,172

Non-cash Interest Expense

 

 

  

Amortization of debt discount/transaction costs- 2023 Notes

 

24

 

1,365

Amortization of debt discount/transaction costs- 2025 Notes

113

1,162

Amortization of debt discount/transaction costs- 2027 Notes

100

987

Total Interest Expense

$

2,704

$

6,734

The Company determined the Convertible Senior2023 Notes, is a 2025 notes, and 2027 Notes are Level2 liabilityliabilities in the fair value hierarchy and had an estimated its fair value as $330.9at March 31, 2022 of $20.7 million, at September 30, 2017.$180.0, and $259.9 million, respectively.

Capped Call Transactions

In connection with the offering of the 2027 Notes, on May 13, 2020, the Company entered into privately negotiated capped call transactions (the “Capped Call Transactions”), pursuant to capped call confirmations, covering the total principal amount of the 2027 Notes for an aggregate premium of $10.3 million. The Capped Call Transactions are expected generally to reduce the potential dilution to the Company’s common stock upon any conversion of the 2027 Notes and/or offset any cash payments the Company is required to make in excess of the aggregate principal amount of converted 2027 Notes, as the case may be, with such reduction and/or offset subject to a cap based on the capped price of the Capped Call Transactions. The Capped Call Transactions exercise price is equal to the initial conversion price of the 2027 Notes, and the capped price of the Capped Call Transactions is approximately $18.46 per share and is subject to certain adjustments under the terms of the capped call confirmations.

The Capped Call Transactions are separate transactions entered into by the Company with the capped call counterparties, are not part of the terms of the 2027 Notes and do not change the holders’ rights under the 2027 Notes. Holders of the 2027 Notes do not have any rights with respect to the Capped Call Transactions. The cost of the Capped Call Transactions is not expected to be tax-deductible as the Company did not elect to integrate the Capped Call Transactions into the 2027 Notes for tax purposes. The Company used a portion of the net proceeds from the offering of the 2027 Notes to pay for the Capped Call Transactions, and the cost of the Capped Call Transactions was recorded as a reduction of the Company’s additional paid-in capital in the accompanying consolidated financial statements.

19

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

Revolving Credit Facility

On December 16, 2021, the Company entered into a loan and security agreement providing for a senior secured revolving credit facility in an aggregate principal amount of $150 million (the “Credit Facility”), including a $15 million letter of credit sublimit. The Credit Facility is guaranteed by the Company’s direct material U.S. subsidiaries, subject to customary exceptions. Borrowings under the Credit Facility are secured by a first-priority lien on substantially all of the assets of the Company, subject to customary exceptions. The Credit Facility has a term of five years, maturing on December 16, 2026, or earlier if certain liquidity measures are not met prior to the 2025 Notes maturing. Subject to certain conditions and the receipt of commitments from the lenders, the Loan and Security Agreement allows for revolving commitments under the Credit Facility to be increased by up to $75 million. The existing lenders under the Credit Facility are entitled, but not obligated, to provide such incremental commitments.

Borrowings will bear interest at a floating rate which can be, at the Company’s option, either (a) an alternate base rate plus an applicable rate ranging from 0.50% to 1.25% or (b) a SOFR rate (with a floor of 0.00%) for the specified interest period plus an applicable rate ranging from 1.50% to 2.25%, in each case, depending on the Company’s Secured Net Leverage Ratio (as defined in the Loan and Security Agreement). The Company will pay an unused commitment fee ranging from 0.25% to 0.35% based on unused capacity under the Credit Facility and the Company’s Secured Net Leverage Ratio. The Company may use the proceeds of borrowings under the Credit Facility to pay transaction fees and expenses, provide for its working capital needs and reimburse drawings under letters of credit and for other general corporate purposes.

The Loan and Security Agreement contains customary affirmative covenants for transactions of this type, including, among others, the provision of financial and other information to the administrative agent, notice to the administrative agent upon the occurrence of certain material events, preservation of existence, maintenance of properties and insurance, compliance with laws, including environmental laws, the provision of additional guarantees, and an affiliate transactions covenant, subject to certain exceptions. The Loan and Security Agreement contains customary negative covenants, including, among others, restrictions on the ability to merge and consolidate with other companies, incur indebtedness, refinance our existing convertible notes, grant liens or security interests on assets, make investments, acquisitions, loans, or advances, pay dividends, and sell or otherwise transfer assets.

The Loan and Security Agreement contains financial maintenance covenants that require the Borrower to maintain an Interest Coverage Ratio (as defined in the Loan and Security Agreement) of not less than 3.00 to 1.00, a Total Net Leverage Ratio (as defined in the Loan and Security Agreement) of not more than 4.50 to 1.00, and a Secured Net Leverage Ratio (as defined in the Loan and Security Agreement) of not more than 2.50 to 1.00, in each case, tested at the end of each fiscal quarter commencing with the fiscal quarter ending March 31, 2022. The Loan and Security Agreement also provides for a number of customary events of default, including, among others: payment defaults to the lenders; voluntary and involuntary bankruptcy proceedings; covenant defaults; material inaccuracies of representations and warranties; certain change of control events; material money judgments; and other customary events of default. The occurrence of an event of default could result in the acceleration of obligations and the termination of lending commitments under the Loan and Security Agreement.

NaN amounts were outstanding under the Credit Facility as of March 31, 2022 or December 31, 2021.

Other Liabilities

Other liabilities at September 30, 2017March 31, 2022 and December 31, 2021 included deferred compensation(i) medical and dental benefits for former executives of $4.5 million,$1.8 million; (ii) asset retirement obligations of $3.3 million, medical$2.8 million; and dental benefits(iii) income tax payables of $2.5$0.4 million.

20

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

Note 5 — Commitments and Contingencies

Leases

The Company’s operating leases primarily include real estate leases for properties used for manufacturing, R&D activities, sales and service, and administration, as well as certain equipment leases. Some leases may include options to renew for a period of up to 5 years, while others may include options to terminate the lease. The weighted average remaining lease term of the Company’s operating leases as of March 31, 2022 was 12 years, and the weighted average discount rate used in determining the present value of future lease payments was 5.6%.

The following table provides the maturities of lease liabilities at March 31, 2022:

Operating

    

Leases

(in thousands)

Payments due by period:

2022

$

3,665

2023

4,099

2024

3,887

2025

3,317

2026

3,496

Thereafter

35,960

Total future minimum lease payments

54,424

Less: Imputed interest

(17,638)

Total

$

36,786

Reported as of March 31, 2022

Accrued expenses and other current liabilities

$

4,376

Long-term operating lease liabilities

32,410

Total

$

36,786

Operating lease cost for the three months ended March 31, 2022 and 2021 were $1.9 million and acquisition related accruals$1.3 million, respectively. Variable lease cost for the three months ended March 31, 2022 and 2021 were $0.5 million and $0.4 million, respectively. Additionally, the Company has an immaterial amount of $0.7 million. At December 31, 2016, other liabilities primarily consisted of a non-current income tax payable of $4.9 million.

Note 6 - Commitments and Contingencies

Minimum lease commitments

At September 30, 2017, Veeco’s total future minimum lease payments under non-cancelableshort-term leases. Operating cash outflows from operating leases (exclusive of renewal options) are payable as follows:for the three months ended March 31, 2022 and 2021 were $1.9 million and $1.7 million, respectively.

 

 

Operating
Leases

 

 

 

(in thousands)

 

Payments due by period:

 

 

 

2017

 

$

1,678

 

2018

 

5,474

 

2019

 

5,002

 

2020

 

4,763

 

2021

 

1,807

 

Thereafter

 

4,505

 

Total

 

$

23,229

 

Purchase commitmentsCommitments

Veeco has purchase commitments of $151.7$235.4 million at September 30, 2017,March 31, 2022, substantially all of which become due within one year.

Bank guaranteesGuarantees

Veeco has bank guarantees and letters of credit issued by a financial institution on its behalf as needed. At September 30, 2017,March 31, 2022, outstanding bank guarantees and standby letters of credit totaled $3.7$5.3 million, and unused bank guarantees and letters of credit of $67.9$17.4 million were available to be drawn upon.

21

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

Legal proceedingsProceedings

On September 21, 2017, Blueblade Capital Opportunities LLCJune 8, 2018, an Ultratech shareholder who received Veeco stock as part of the consideration for the Ultratech acquisition filed a purported class action complaint in the Superior Court of the State of California, County of Santa Clara, captioned Wolther v. Maheshwari et al., Case No. 18CV329690, on behalf of purported beneficial owners of 440,100himself and others who purchased or acquired shares of Veeco pursuant to the registration statement and prospectus which Veeco filed with the SEC in connection with the Ultratech common stock,acquisition (the “Wolther Action”). On August 2 and August 8, 2018, 2 purported class action complaints substantially similar to the Wolther Action were filed an action against Ultratechon behalf of different plaintiffs in Delaware Court of Chancery requesting an appraisalthe same court as the Wolther Action. These cases have been consolidated with the Wolther Action, and a consolidated complaint was filed on December 11, 2018. The consolidated complaint seeks to recover damages and fees under Sections 11, 12, and 15 of the valueSecurities Act of their Ultratech stock pursuant to 8 Del. C. §262.  The Company believes that the merger price, which was the product of arms-length negotiations, was fair and reasonable, and intends to contest the appraisal claim.  Discovery1933 for, among other things, alleged false/misleading statements in the matter has commenced.

On April 12, 2017, the Company filed a patent infringement complaint in the U.S. District Court for the Eastern District of New York against SGL Carbon, LLCregistration statement and SGL Carbon SE (collectively, “SGL”), alleging infringement of patents relating to wafer carrier technology used in MOCVD equipment.  The complaint alleges that SGL infringes Veeco’s patents by making and selling certain wafer carriers to Veeco’s competitor, Advanced Micro-Fabrication Equipment, Inc. (“AMEC”). On November 2, 2017, the U.S. District Court granted the Company’s motion for a preliminary injunction prohibiting SGL from shipping wafer carriers using the Company’s patented technology without the Company’s express authorization. The Company continues to seek a post-trial permanent injunction and monetary damages against SGL.

On July 13, 2017, AMEC filed a patent infringement complaint against Veeco Instruments Shanghai Co., Ltd. (“Veeco Shanghai”) with the Fujian High Court in China, alleging that the Company’s MOCVD products infringed a Chinese utility model patentprospectus relating to the synchronous movement engagement mechanismUltratech acquisition, relating primarily to the alleged failure to disclose delays in the advanced packaging business, increased MOCVD competition in China, and an intellectual property dispute. In October 2021, Veeco and the court-appointed class representatives signed an agreement to settle the Wolther Action on a chemical vapor deposition reactorclass-wide basis for $15.0 million, subject to court approval and seeking injunctive reliefclass members’ opportunity to object and monetary damages againstopt-out, which is included within “Accrued expenses and other current liabilities” in the Consolidated Balance Sheets as of March 31, 2022 and December 31, 2021. The settlement amount will be funded by insurance carriers, the receivable for which is included in “Prepaid expenses and other current assets” in the Consolidated Balance Sheets as of March 31, 2022 and December 31, 2021.

On December 21, 2018, a purported Veeco Shanghai. The Company believes this complaint is without merit and intends to vigorously defend against these allegations. The Company hasstockholder filed a petition for invalidation of this patent withderivative action in the Chinese Patent Reexamination Board (“PRB”).  The Fujian HighSuperior Court has suspended the infringement case against Veeco pending the outcome of the invalidation proceeding atState of California, County of Santa Clara, captioned Vladimir Gusinsky Revocable Trust v. Peeler, et al., Case No. 18CV339925, on behalf of nominal defendant Veeco. The complaint seeks to assert claims for breach of fiduciary duty, waste of corporate assets, and unjust enrichment against current and former Veeco directors premised on purported misstatements and omissions in the PRB.registration statement relating to the Ultratech acquisition. Veeco is defending this matter vigorously. On January 25, 2021, the court granted the defendants’ demurrer without leave to amend effecting the dismissal of the case. On March 26, 2021, plaintiff filed its notice of appeal of the trial court’s order granting defendants’ demurrer without leave to amend. In April 2022, Veeco and plaintiff reached an agreement in principle to settle the Derivative Action subject to court approval. As part of the settlement and subject to court approval, Veeco will make certain revisions to its internal Disclosure Committee Charter and its director education program. The agreement also provides that, subject to court approval, plaintiff will receive $0.3 million for fees and expenses. This amount will be funded by insurance that Veeco maintains in the normal course of its business.

 

The Company is involved in various other legal proceedings arising in the normal course of business. The Company does not believe that the ultimate resolution of these matters will have a material adverse effect on its consolidated financial position, results of operations, or cash flows.

Note 6 — Derivative Financial Instruments

The Company is exposed to financial market risks arising from changes in currency exchange rates. Changes in currency exchange rates could affect the Company’s foreign currency denominated monetary assets and liabilities and forecasted cash flows. The Company enters into monthly forward derivative contracts from time to time with the intent of mitigating a portion of this risk. The Company only uses derivative financial instruments in the context of hedging and not for speculative purposes and had not designated its foreign exchange derivatives as hedges. Accordingly, changes in fair value from these contracts are recorded as “Other operating expense (income), net” in the Company’s Consolidated Statements of Operations. The Company executes derivative transactions with highly rated financial institutions to mitigate counterparty risk.

22

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

The Company did not have any outstanding derivative contracts at March 31, 2022 or December 31, 2021. Additionally, the Company did 0t have any gains or losses from currency exchange derivatives during the three months ended March 31, 2022 and 2021.

Note 7 - Equity

Statement of Stockholders’ Equity

The following tables present the changes in Stockholders’ Equity:

    

    

    

    

    

Accumulated

    

Additional

Other

Common Stock

Paid-in

Accumulated

Comprehensive

Shares

Amount

Capital

Deficit

Income

Total

(in thousands)

Balance at December 31, 2021

 

50,653

$

507

$

1,116,921

$

(681,283)

$

1,483

$

437,628

Cumulative effect of change in accounting principle - adoption of ASU 2020-06

 

 

(56,801)

 

12,541

 

 

(44,260)

Net income

 

 

 

 

13,330

 

 

13,330

Other comprehensive income (loss), net of tax

 

 

 

 

 

(822)

 

(822)

Share-based compensation expense

 

 

 

4,481

 

 

 

4,481

Net issuance under employee stock plans

 

590

6

(6,793)

(6,787)

Balance at March 31, 2022

 

51,243

$

513

$

1,057,808

$

(655,412)

$

661

$

403,570

    

    

    

    

    

Accumulated

    

Additional

Other

Common Stock

Paid-in

Accumulated

Comprehensive

Shares

Amount

Capital

Deficit

Income

Total

(in thousands)

Balance at December 31, 2020

 

49,724

$

497

$

1,113,352

$

(707,321)

$

1,846

$

408,374

Net income

 

 

 

 

2,494

 

 

2,494

Other comprehensive income (loss), net of tax

 

 

 

 

 

(19)

 

(19)

Share-based compensation expense

 

 

 

3,237

 

 

 

3,237

Net issuance under employee stock plans

459

5

(1,630)

(1,625)

Balance at March 31, 2021

 

50,183

$

502

$

1,114,959

$

(704,827)

$

1,827

$

412,461

Accumulated Other Comprehensive Income (“AOCI”)

The following table presents the changes in the balances of each component of AOCI, net of tax:

 

 

 

 

Unrealized

 

 

 

 

 

Foreign Currency

 

Gains (Losses) on
Available for Sale

 

 

 

 

 

Translation

 

Securities

 

Total

 

 

 

(in thousands)

 

Balance - December 31, 2016

 

$

1,797

 

$

(20

)

$

1,777

 

Other comprehensive income (loss)

 

25

 

10

 

35

 

Balance - September 30, 2017

 

$

1,822

 

$

(10

)

$

1,812

 

Unrealized

Gains (Losses)

Foreign

on Available

Currency

for Sale 

    

Translation

    

Securities

    

Total

(in thousands)

Balance - December 31, 2021

$

1,814

$

(331)

$

1,483

Other comprehensive income (loss)

 

(3)

 

(819)

 

(822)

Balance - March 31, 2022

$

1,811

$

(1,150)

$

661

There were minimal reclassifications from AOCI into net income for the ninethree months ended September 30, 2017.March 31, 2022 and 2021.

23

Table of Contents

For the nine months ended September 30, 2017, Additional Paid-in Capital increased approximately $228.8 million related to 7.2 million shares issued for the Ultratech merger consideration, $47.5 million relatedVeeco Instruments Inc. and Subsidiaries

Notes to the issuance of the Convertible Senior Notes including deferred tax impact, and $11.4 million related to on-going share-based compensation activities.

Consolidated Financial Statements - continued

(unaudited)

Note 8 - Share-based compensationCompensation

Restricted share awards are issued to employees and board of directors that are subject to specified restrictions and a risk of forfeiture. The restrictions typically lapse over one to fivefour years and may entitle holders to dividends and voting rights. Other types of share-based compensation include performance share awards, performance share units, and restricted share units (collectively with restricted share awards, “restricted shares”), as well as options to purchase common stock.

Share-based compensation expense was recognized in the following line items in the Consolidated Statements of Operations for the three and nine months ended September 30, 2017March 31, 2022 and 2016:2021:

Three months ended March 31,

    

2022

    

2021

    

    

 

Three months ended September 30,

 

Nine months ended September 30,

 

 

2017

 

2016

 

2017

 

2016

 

 

(in thousands)

 

(in thousands)

Cost of sales

 

$

740

 

$

607

 

$

1,898

 

$

1,639

 

 

$

938

 

$

495

 

 

Research and development

 

849

 

993

 

1,986

 

3,032

 

1,257

817

Selling, general, and administrative

 

3,714

 

2,143

 

10,182

 

7,462

 

2,286

1,925

Restructuring

 

867

 

 

1,707

 

 

Acquisition costs

 

 

 

4,203

 

 

Total

 

$

6,170

 

$

3,743

 

$

19,976

 

$

12,133

 

$

4,481

$

3,237

For the ninethree months ended September 30, 2017,March 31, 2022, equity activity related to stock options was as follows:

 

 

Number of

 

Weighted
Average

 

 

 

Shares

 

Exercise Price

 

 

 

(in thousands)

 

 

 

 

Balance - December 31, 2016

 

1,576

 

$

35.18

 

Granted

 

 

 

Exercised

 

(18

)

30.03

 

Expired or forfeited

 

(129

)

37.03

 

Balance - September 30, 2017

 

1,429

 

35.07

 

Weighted 

Number of

Average

    

Shares

    

Exercise Price

(in thousands)

Balance - December 31, 2021

443

$

32.15

Expired

(4)

31.01

Balance - March 31, 2022

439

32.16

For the ninethree months ended September 30, 2017,March 31, 2022, equity activity related to non-vested restricted shares and performance shares was as follows:

 

 

 

 

Weighted
Average

 

 

 

Number of

 

Grant Date

 

 

 

Shares

 

Fair Value

 

 

 

(in thousands)

 

 

 

Balance - December 31, 2016

 

1,949

 

$

23.85

 

Granted

 

642

 

29.35

 

Assumed from Ultratech

 

338

 

31.75

 

Vested

 

(695

)

27.12

 

Forfeited

 

(173

)

26.39

 

Balance - September 30, 2017

 

2,061

 

25.85

 

    

    

Weighted

Average

Number of

Grant Date

Shares

Fair Value

(in thousands)

Balance - December 31, 2021

2,083

$

17.33

Granted

896

32.60

Performance award adjustments

85

14.03

Vested

(600)

15.53

Forfeited

(23)

17.53

Balance - March 31, 2022

2,441

23.26

Note 9 - Income Taxes

Income taxes are estimated for each of the jurisdictions in which the Company operates. Deferred income taxes reflect the net tax effect of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes, as well as the tax effect of carryforwards. Realization of net deferred tax assets is dependent on future taxable income. At September 30, 2017,March 31, 2022, the Company’s U.S. deferred tax assets are fully offset by a valuation allowance since the Company cannot conclude that it is more likely than not that these future benefits will be realized.

24

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

At the end of each interim reporting period, the effective tax rate is aligned with expectations for the full year. This estimate is used to determine the income tax provision on a year-to-date basis and may change in subsequent interim periods. If necessary, the year-to-date tax benefit for interim period losses is limited to the amount that could be recognizable at the end of the fiscal year.

Income (loss) before income taxes and income tax expense (benefit) for the three and nine months ended September 30, 2017March 31, 2022 and 20162021 were as follows:

Three months ended March 31,

 

    

2022

    

2021

 

 

Three months ended September 30,

 

Nine months ended September 30,

 

 

2017

 

2016

 

2017

 

2016

 

 

(in thousands)

 

 

 

 

 

Income (loss) before income taxes

 

$

(23,674

)

$

(68,462

)

$

(64,146

)

$

(114,535

)

(in thousands)

 

Income before income taxes

$

13,714

$

2,792

Income tax expense (benefit)

 

$

(1,790

)

$

1,136

 

$

(24,969

)

$

2,677

 

 

$

384

 

$

298

The net incomeCompany’s tax benefitexpense for the three months ended September 30, 2017March 31, 2022 was comprised of a net benefit of $2.2$0.4 million, relatedcompared to $0.3 million for the Company’s U.S. operations, and a netcomparable prior period. The 2022 tax expense included an expense of $0.4$0.3 million related to the Company’s non-U.S. operations. The net income tax benefit for the nine months ended September 30, 2017 was comprised of a net benefit of $21.6 millionoperations and $3.4$0.1 million related to the Company’s U.S. and non-U.S. operations, respectively.

domestic operations. The net income2021 tax benefit from the Company’s U.S. operations was primarily attributable to a tax benefitexpense included an expense of $2.2 million and $23.5 million for losses incurred during the three and nine months ended September 30, 2017, respectively. Under the intraperiod tax allocation rules, the deferred tax liability created upon the issuance of the Convertible Senior Notes and recorded through Additional Paid-in Capital is treated as a source of income, which enables the Company to recognize a benefit for the U.S. loss before income taxes through operations during fiscal 2017. The tax benefit related to the issuance of the Convertible Senior Notes will not recur in future years. This benefit was partially offset by a deferred provision of approximately $1.9$0.2 million related to tax amortization on indefinite-lived intangible assets for the nine months ended September 30, 2017.

The net income tax benefit of $3.4 million for the nine months ended September 30, 2017, from the Company’s non-U.S. operations was primarily attributableand $0.1 million related to the Company’s determination in the first quarter of 2017 that it was more likely than not that it will meet the requirements of an existing foreign tax incentive agreement.  As a result, the Company remeasured this uncertain tax position and recognized a $6.3 million benefit during the first quarter, which is comprised of a reversal of a $4.9 million tax liability established in previous periods and the recognition of a deferred tax benefit of $1.4 million related to certain foreign net operating losses generated in prior years that are now determined to be realizable. This benefit was partially offset by a current year tax expense of approximately $3.1 million attributed to the profitable non-U.S. operations, of which approximately $0.4 million was recorded duringdomestic operations. For the three months ended September 30, 2017.

ForMarch 31, 2022 and 2021, the three and nine months ended September 30, 2016, the Company did not provideCompany’s U.S. deferred tax assets are fully offset by a current tax benefit on U.S. pre-tax lossesvaluation allowance since the Company could notcannot conclude that it is more likely than not that thethese future benefits wouldwill be realized. The domestic tax expense for both periods is primarily relatedattributable to indefinite-livedthe tax amortization of indefinite lived intangible assets that are amortized for tax purposes butis not for financial reporting purposes, as well as taxes attributedavailable to the profitable non-U.S. operations. Theoffset U.S. deferred tax liability createdassets. The foreign tax expense for both periods is primarily attributable to non-US operations profits and foreign withholding taxes on unremitted earnings, offset by the tax deductible expense cannot be used to offset existing deferred taxamortization of intangible assets.

Note 10 - Segment Reporting and Geographic Information

Veeco operates and measures its results in one1 operating segment and continues to do so with the integration of

Ultratech’s business activities. As a result, the Companytherefore has one1 reportable segment: the design, development, manufacture, sales, and support of semiconductor and thin film process equipment primarily sold to make electronic devices.

Veeco categorizes its revenue bysales into the key markets intofollowing 4 end-markets:

Semiconductor

The Semiconductor market refers to early process steps in logic and memory applications where silicon wafers are processed. There are many different process steps in forming patterned wafers, such as deposition, etching, masking, and doping, where the microchips are created but remain on the silicon wafer. This market includes mask blank production for extreme ultraviolet (“EUV”) lithography. This market also includes Advanced Packaging which it sells.  Asrefers to a resultportfolio of the acquisitionwafer-level assembly technologies that enable improved performance of Ultratech, the Company’s four key markets are now: LED Lighting, Display &electronic products, such as smartphones, high-end servers, and graphical processors.

Compound Semiconductor

The Compound Semiconductor (formerly Lighting, Display & Power Electronics); Advanced Packaging, MEMS & RF; Scientific & Industrial, which now includes Data Storage, which was formerly a separate category; and Front-End Semiconductor, which was formerly included in the Scientific & Industrial market category.

LED Lighting, Display & Compound Semiconductor

LED Lighting refers to Light Emitting Diode (“LED”) and semiconductor illumination sources used in various applications including, but not limited to, displays such as backlights, general lighting, automotive running lights, and headlamps. Display refers to LEDs used for displays and Organic Light Emitting Diode (“OLED”) displays found in outdoor display/signage applications, TVs, smartphones, wearable devices, and tablets. Compound Semiconductor includes Photonics, Power Electronics, RF Filters and Radio Frequency (“RF”) Devices.Amplifiers, and Solar applications. Photonics refers to light source technologies and laser-based solutions for 3D sensing, datacom and telecom applications. This includes micro-LED, laser diodes, Vertical Cavity Surface Emitting Lasersedge emitting lasers and vertical cavity surface emitting lasers (“VCSEL”VCSELs”) in 3D sensing and communications, and various other optical devices.. Power Electronics refers to semiconductor devices such as rectifiers, inverters and converters for the control and conversion of electric power. RF devices refers to radio frequency emitting and receiving devices that enable wireless communications. Such devices include power amplifiers, switches, and transceivers forin applications such as mobilefast or wireless charging of consumer electronics and automotive applications. RF power amplifiers and filters (including handsetssurface acoustic wave (“SAW”) and base stations), defense, automotive, and the internet of things.

Advanced Packaging, MEMS & RF Filters

Advanced Packaging includes a portfolio of wafer-level assembly technologies that enable the miniaturization and performance improvement of electronic products, such as smartphones, smartwatches, tablets, and laptops. Micro-Electro Mechanical Systemsbulk acoustic wave (“MEMS”BAW”) includes tiny mechanical devices such as sensors, switches, mirrors, and actuators embedded in semiconductor chipsfilters) are used in vehicles, smartphones, tablets, and games. RF Filters refers to RF filters used in5G communications infrastructure, smartphones, tablets, and mobile devices. They

25

Table of Contents

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

make use of radio waves for wireless broadcasting and/or communications. Solar refers to power obtained by harnessing the energy of the sun through the use of compound semiconductor devices such as photovoltaics.

Data Storage

Data Storage refers to the Hard Disk Drive (“HDD”) market, for which our systems enable customers to manufacture thin film magnetic heads for hard disk drives as part of large capacity storage applications.

Scientific & IndustrialOther

Scientific & Other refers to advanced materials research at university research institutions, industry research institutions, industry consortiums, and government research agencies. Industrial refers to large-scale producta range of manufacturing applications including data storageoptical coatings (laser mirrors, optical filters, and optical coatings: thin layers of material deposited on a lens or mirror that alters how light reflects and transmits.anti-reflective coatings).

Front-End Semiconductor

Front-End Semiconductor refers to the early steps in the process of integrated circuit fabrication where the microchips are created but still remain on the silicon wafer. This category includes Laser Spike Anneal, Ion Beam etch for front-end semiconductor applications, and Ion Beam deposition for EUV mask blanks.

Sales by end-market and geographic region for the three and nine months ended September 30, 2017March 31, 2022 and 20162021 were as follows:

 

 

Three months ended September 30,

 

Nine months ended September 30,

 

 

 

2017

 

2016

 

2017

 

2016

 

 

 

(in thousands)

 

Sales by end-market

 

 

 

 

 

 

 

 

 

LED Lighting, Display & Compound Semiconductor

 

$

59,721

 

$

49,427

 

$

170,546

 

$

97,985

 

Advanced Packaging, MEMS & RF

 

22,775

 

12,092

 

55,756

 

52,400

 

Scientific & Industrial

 

33,145

 

20,997

 

86,917

 

82,726

 

Front-End Semiconductor

 

16,231

 

2,966

 

28,105

 

5,731

 

Total

 

$

131,872

 

$

85,482

 

$

341,324

 

$

238,842

 

Sales by geographic region

 

 

 

 

 

 

 

 

 

United States

 

$

34,723

 

$

19,104

 

$

73,256

 

$

66,550

 

China

 

15,197

 

21,238

 

81,811

 

54,621

 

EMEA(1)

 

17,243

 

19,703

 

57,312

 

61,999

 

Rest of World

 

64,709

 

25,437

 

128,945

 

55,672

 

Total

 

$

131,872

 

$

85,482

 

$

341,324

 

$

238,842

 

Three months ended March 31,

    

2022

2021

    

    

(in thousands)

Sales by end-market

Semiconductor

$

77,620

$

51,631

Compound Semiconductor

37,109

24,751

Data Storage

 

21,595

 

40,980

Scientific & Other

 

20,102

 

16,352

Total

$

156,426

$

133,714

Sales by geographic region

United States

$

47,471

$

45,162

EMEA(1)

21,425

13,625

China

30,381

20,007

Rest of APAC

56,922

54,877

Rest of World

 

227

 

43

Total

$

156,426

$

133,714


(1) EMEA consists of Europe, the Middle East, and Africa

(1)EMEA consists of Europe, the Middle East, and Africa

For geographic reporting, sales are attributed to the location in which the customer facility is located.

26

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Cautionary Statement Regarding Forward Looking Statements

Our discussion below constitutes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. When used in this Report, the words “believes,” “anticipates,” “expects,” “estimates,” “targets,” “plans,” “intends,” “will,” and similar expressions related to the future are intended to identify forward-looking statements. All forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from projected results. You should not place undue reliance on any forward-looking statements, which speak only as of the dates they are made.

Executive Summary

On May 26, 2017, we completed the acquisitionWe are an innovative manufacturer of Ultratech.  Ultratech designs, manufactures, and markets lithography,semiconductor process equipment. Our proven ion beam, laser annealing, and inspection equipment for manufacturers of semiconductor devices, including front-end semiconductor manufacturing and advanced packaging. Ultratech also designs, manufactures, and markets atomic layer deposition (“ALD”) equipment for scientific and industrial applications. Ultratech’s customers are primarily located throughout the United States, EMEA, China, Japan, Taiwan, Singapore, and Korea. The results of Ultratech’s operations have been included in the consolidated financial statements since the date of acquisition.

Together with Ultratech, we design, manufacture, and market semiconductor process equipment aligned to meet the demands of key global trends such as energy conservation, mobility, and connectivity. Ourlithography, MOCVD lithography, laser annealing, ion beam, and single wafer etch and& clean technologies play an integral role in producing LEDs for solid-state lightingthe fabrication and displays and in the fabricationpackaging of advanced semiconductor devices. With equipment designed to optimize performance, yield and cost of ownership, we holdVeeco holds leading technology leadership positions in the markets we serve. To learn more about Veeco’s systems and service offerings, visit www.veeco.com.

COVID-19 Update

As a result of the continued COVID-19 pandemic, governmental authorities and businesses continue to implement numerous and constantly evolving measures to limit the spread of the virus, such as travel bans and restrictions, limits on gatherings, quarantines, shelter-in-place orders, vaccine mandates, and business shutdowns. We have important manufacturing operations in the U.S. and Singapore, and sales and support operations in China, Germany, Japan, Malaysia, Philippines, Singapore, South Korea, Thailand, Taiwan and the United Kingdom, all of which continue to be affected by the COVID-19 pandemic.

Measures providing for business shutdowns generally exclude certain essential services, and those essential services include critical infrastructure and the businesses that support that critical infrastructure. Our operations are considered part of the critical and essential infrastructure defined by applicable government authorities, and, although governmental measures to contain the pandemic may be modified or extended, our manufacturing facilities remain open. We believe our diverse product offerings and the critical nature of certain of our products for infrastructure continue to insulate us, to some extent, from the ongoing adverse effects of the pandemic; however, a prolonged economic downturn will adversely affect our customers, which could have a material adverse effect on our revenues, particularly if customers from whom we derive a significant amount of revenue reduce or delay purchases to mitigate the impacts of the pandemic or fail to make payments to us on time or at all.

We serve a global and highly interconnected customer base across the Asia-Pacific region, Europe, and North America. Our net sales to customers located outside of the United States represented approximately 70% of our total net sales for the three months ended March 31, 2022, and 62% and 68% for the years ended December 31, 2021 and 2020, respectively, and we expect that net sales to customers outside the United States will continue to represent a significant percentage of our total net sales. As a result, our business will be adversely impacted by further deterioration in global economic conditions, particularly in markets in Asia and Europe.

We are also seeing the effects of the macroeconomic inflationary cost environment and supply chain disruptions due to strained transportation capacity, labor shortages, and high global demand. These effects include longer lead times and increased costs. We are taking proactive steps to manage the impact on our business, including buying in advance and re-sourcing components on a more frequent basis. We continue to monitor our global supply chain and may experience additional disruptions in future periods, which could cause challenges in our ability to obtain raw materials or components required to manufacture our products.

Like many in our industry, we are managing through the effects of the COVID-19 pandemic. Although the full extent of the COVID-19 pandemic’s impact on our business, results of operations, supply chain, and growth cannot be predicted

27

or quantified, we proactively identified potential challenges to our business and have been executing business continuity activities to manage disruptions in our business and continue to provide critical infrastructure to our customers. In response to the pandemic, we continue or intend to take the following steps, among others, to keep our employees safe, minimize the spread of the virus, and serve our customers:

maintain flexible health and safety protocols in response to local circumstances at our manufacturing facilities, including extensively and frequently disinfecting our facilities and providing protective equipment;

continue remote working arrangements for employees that do not need to be physically present on the manufacturing floor or at customer facilities;

implement virtual meetings, customer demos, and factory acceptances where feasible to enable customers to review data and performance of their system in our factory remotely via live video;

perform service and support activities remotely where feasible to resolve customer issues and enable our customers to maintain their operations;

proactively identify gaps in our supply chain and re-source components in order to maintain our customer shipment commitments and mitigate single points of failure;

monitor our IT systems and implementing contingency and disaster recovery plans to support our IT infrastructure to ensure that our systems remain continuously operative; and

continue to monitor and, if necessary, reduce our operating expenses and capital expenditures to maintain financial flexibility and profit margins.

While these served markets.steps have been effective so far, there could be additional challenges ahead that may impact either our operations or those of our customers, which could have a negative effect on our financial performance, including productivity and capacity impacts as a result of the ongoing pandemic. We expect these measures to continue until we determine that the COVID-19 pandemic is adequately contained for the purposes of our business, and we may take further actions as government authorities require or recommend or as we determine to be in the best interests of our employees, customers and suppliers. As a result, we may incur additional expenses in future periods in response to the pandemic, which could adversely affect our financial position, results of operations, or cash flows. In addition, we may revise our approach to these initiatives or take additional actions to meet the needs of our employees and customers, and mitigate the impact of the pandemic on our business.

Business Update

We categorize our revenue by the key marketsend-markets into which we sell. Our four key marketsend-markets are: LED Lighting, Display &Semiconductor; Compound Semiconductor; Advanced Packaging, MEMS & RF;Data Storage; and Scientific & Industrial; and Front-End Semiconductor.Other.

Sales in the LED Lighting, Display &Semiconductor market grew significantly both from the prior quarter and from the year ago quarter, driven by our laser annealing systems for logic devices, lithography systems for Advanced Packaging and multiple Ion Beam deposition chambers for EUV mask blanks. We continue to build momentum for our laser annealing solutions with advanced node logic customers and have been named production tool of record for an application step with a third leading-edge logic customer. We continue to innovate and have been working with DRAM manufacturers and existing logic customers on their next manufacturing nodes. We also continue to deliver our laser annealing systems to trailing node logic manufacturers. Our lithography systems for Advanced Packaging are aligned with longer-term growth of FOWLP and other Advanced Packaging applications. We view our AP lithography product line as a key enabler for our customers as they seek to improve device performance. Additionally, the ongoing adoption of EUV Lithography for advanced node, semiconductor manufacturing continues to drive demand for our mask blank systems. During the first quarter, we announced that a third customer has entered the EUV mask blank market by ordering an ion beam deposition system from us. Overall, our technology and market strategy are well aligned with trends such as artificial intelligence,

28

mobile connectivity and high-performance computing that drive the Semiconductor market. We expect continued growth in this market.

We address the Compound Semiconductor market were driven by the continued shipment of MOCVD and PSP systems to customers in Europe, China, and Southeast Asia, along with a large MBE system shipment in the Solar application space. The largest applications for LEDs are solid state lighting, followed by TV displays. Over the past few quarters, demand has increased for larger LCD TV displays, which require relatively more LEDs to backlight than smaller display sizes. We have also seen an increase in LED demand for fine-pitch digital signage. These trends have driven an increase in demand for our MOCVD equipment and build-up in our MOCVD backlog. Our broad portfolio of technologies including primarily Wet Processing and MOCVD, technologies hasalong with MBE and Ion Beam, all of which have been developed to support emerging applications such as 5G driven RF device/filter manufacturing, Gallium Nitride power electronics, and photonics applications including edge-emitting lasers and micro-LEDs. Sales in the most significant industry trends, including developing mid-power LEDs, utilizing larger wafer sizes,Compound Semiconductor market increased over the prior quarter and optimizing cost-of-ownership. Our TurboDisc® EPIK700 GaNfrom the year ago quarter. We shipped systems for RF Devices, power electronics and micro-LED applications such as augmented & virtual reality and large displays, and we expect future growth to come from MOCVD and other system continues to win new business for blue LEDs. Our TurboDisc K475i AsP MOCVD system targets red-orange-yellow LEDs, laser diodes, and high-efficiency triple junction photovoltaic solar cells and continues to gain market momentum. Duringshipments in the quarter we released our latest MOCVD system, the EPIK868, offering a lower cost and higher productivity solution for our customers. The EPIK868 was designed to meet the needs of our customers in China, demonstrating our long-term commitment to this region. We believe that the expected profits from increased revenues may be partially offset by lower margins based on the current competitive environment.Photonics market.

Sales in the Advanced Packaging, MEMS & RF markets continueData Storage market have been growing for several years, primarily driven by shipments of Ion Beam systems. Demand for our Ion Beam products was driven by cloud-based storage growth. In order to be influencedsuccessful, hard disk drive manufacturers are required increase drive capacity by the mobility trendmanufacturing drives with an increasing number of heads and increasing functionalityaerial density. After multiple years of customers accelerating their capacity additions, we expect a period of slowing capacity adds by our data storage customers, resulting in mobile devices and were driven by Ultratech and PSP salesan expected revenue decline in Advanced Packaging and continued PSP sales for MEMs and RF Filter applications. Sales into the Advanced Packaging market have slowed, largely tied to large Lithography system purchasesour data storage business in 2016 and early 2017, combined with delays in FOWLP (Fan Out Wafer Level Packaging) adoption by some smartphone manufacturers and weak smartphone sales. We remain well positioned for growth as FOWLP and other advance packaging applications grow over the longer term. Our versatile PSP product architecture has allowed us2022 from recent levels. With data proliferation forecasted to continue to generate solidgrow, however, we feel confident about the long-term prospects of our Data Storage business in the MEMs and RF Filter portion of this category.are optimistic 2023 will be a growth year.

Sales in the Scientific & Industrial markets were supportedOther market are largely driven by shipments of AD&E systems for optical coatings and data storage applications, as well as shipments of MBE systemssales to governments, universities, and laboratories.research institutions. Revenue increased both over the prior quarter and from the year ago quarter. We are seeing near term strength due to pent-up demand in this market, but expect long-term growth to be in line with GDP.

Macroeconomic challenges across the industry, including in particular supply chain constraints, have been well publicized. Parts shortages have required that we plan further ahead than usual, and we have undertaken efforts to increase our purchase commitments to secure critical components in a timely manner. While equipment demand from

each individual market may fluctuate quarterwe have been able to quarter, the diverse customer base has historically provided a relatively stable revenue streammeet our financial targets for the company onquarter and fulfil our customers’ most critical demands, material lead times continue to be a combined basis.challenge with respect to our supply chain, limiting our ability to fulfil some of our customers’ demands in a timely manner, as many of our peers have also been experiencing. Additionally, we are experiencing increasing labor, logistics, and material costs, creating additional gross margin pressures. We expect supply shortages and related challenges to persist during 2022, and we continue to monitor our supply chain and work with our suppliers to identify and mitigate potential gaps in an effort to ensure continuity of supply.

SalesOverall, given strong backlog in our semiconductor and compound semiconductor markets, along with our customer engagements and order activity, we continue to expect revenue growth in 2022, despite the Front-End Semiconductor market were primarily driven by Ultratech’s Laser Annealing systems and AD&E’s Photomask systems.ongoing supply chain challenges, as we make progress toward our long-term financial target model.

29

Results of Operations

For the three months ended September 30, 2017March 31, 2022 and 20162021

The following table presents revenue and expense line items reported in our Consolidated Statements of Operations for 2017the indicated periods in 2022 and 20162021 and the period-over-period dollar and percentage changes for those line items. Our results of operations are reported as one business segment, represented by our single operating segment, including the Ultratech business acquired.segment.

 

 

Three months ended September 30,

 

Change

 

 

 

2017

 

2016

 

Period to Period

 

 

 

(dollars in thousands)

 

Net sales

 

$

131,872

 

100%

 

$

85,482

 

100%

 

$

46,390

 

54%

 

Cost of sales

 

78,811

 

60%

 

52,027

 

61%

 

26,784

 

51%

 

Gross profit

 

53,061

 

40%

 

33,455

 

39%

 

19,606

 

59%

 

Operating expenses, net:

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

24,061

 

18%

 

19,892

 

23%

 

4,169

 

21%

 

Selling, general, and administrative                           

 

29,771

 

23%

 

18,396

 

22%

 

11,375

 

62%

 

Amortization

 

12,500

 

9%

 

5,261

 

6%

 

7,239

 

138%

 

Restructuring

 

5,010

 

4%

 

1,798

 

2%

 

3,212

 

179%

 

Acquisition costs

 

783

 

1%

 

 

0%

 

783

 

*

 

Asset impairment

 

2

 

0%

 

56,035

 

66%

 

(56,033

)

(100)%

 

Other, net

 

(140

)

(0)%

 

795

 

1%

 

(935

)

(118)%

 

Total operating expenses, net

 

71,987

 

55%

 

102,177

 

120%

 

(30,190

)

(30)%

 

Operating income (loss)

 

(18,926

)

(14)%

 

(68,722

)

(80)%

 

49,796

 

*

 

Interest income (expense), net

 

(4,748

)

(4)%

 

260

 

0%

 

(5,008

)

*

 

Income (loss) before income taxes

 

(23,674

)

(18)%

 

(68,462

)

(80)%

 

44,788

 

*

 

Income tax expense (benefit)

 

(1,790

)

(1)%

 

1,136

 

1%

 

(2,926

)

*

 

Net income (loss)

 

$

(21,884

)

(17)%

 

$

(69,598

)

(81)%

 

$

47,714

 

*

 

Three Months Ended March 31,

Change

2022

2021

Period to Period

(dollars in thousands)

Net sales

    

$

156,426

    

100%

$

133,714

    

100%

$

22,712

    

17%

    

Cost of sales

 

90,413

 

58%

 

78,800

 

59%

 

11,613

 

15%

Gross profit

 

66,013

 

42%

 

54,914

 

41%

 

11,099

 

20%

Operating expenses, net:

 

  

 

  

 

  

 

 

  

 

Research and development

 

24,117

 

15%

 

21,844

 

16%

 

2,273

 

10%

Selling, general, and administrative

 

22,894

 

15%

 

20,255

 

15%

 

2,639

 

13%

Amortization of intangible assets

 

2,504

 

2%

 

3,354

 

3%

 

(850)

 

(25)%

Other operating expense (income), net

 

(19)

 

-

 

46

 

-

 

(65)

 

*

Total operating expenses, net

 

49,496

 

32%

 

45,499

 

34%

 

3,997

 

9%

Operating income

 

16,517

 

11%

 

9,415

 

7%

 

7,102

 

75%

Interest income (expense), net

 

(2,803)

 

(2)%

 

(6,623)

 

(5)%

 

3,820

 

(58)%

Income before income taxes

 

13,714

 

9%

 

2,792

 

2%

 

10,922

 

*

Income tax expense (benefit)

 

384

 

-

 

298

 

-

 

86

 

29%

Net income

$

13,330

 

9%

$

2,494

 

2%

$

10,836

 

*


* Not meaningful

Not meaningful

Net Sales

The following is an analysis of sales by market and by region:

Three Months Ended March 31,

Change

 

2022

2021

Period to Period

 

 

Three months ended September 30,

 

Change

 

 

2017

 

2016

 

Period to Period

 

 

(dollars in thousands)

 

Sales by market

 

 

 

 

 

 

 

 

 

 

 

 

 

LED Lighting, Display & Compound Semiconductor

 

$

59,721

 

45%

 

$

49,427

 

58%

 

$

10,294

 

21%

 

Advanced Packaging, MEMS & RF

 

22,775

 

17%

 

12,092

 

14%

 

10,683

 

88%

 

Scientific & Industrial

 

33,145

 

25%

 

20,997

 

25%

 

12,148

 

58%

 

Front-End Semiconductor

 

16,231

 

13%

 

2,966

 

3%

 

13,265

 

447%

 

(dollars in thousands)

 

Sales by end-market

    

  

    

  

  

    

  

  

    

  

    

Semiconductor

$

77,620

 

49%

$

51,631

 

39%

$

25,989

 

50%

Compound Semiconductor

 

37,109

 

24%

 

24,751

 

18%

 

12,358

 

50%

Data Storage

 

21,595

 

14%

 

40,980

 

31%

 

(19,385)

 

(47)%

Scientific & Other

 

20,102

 

13%

 

16,352

 

12%

 

3,750

 

23%

Total

 

$

131,872

 

100%

 

$

85,482

 

100%

 

$

46,390

 

54%

 

$

156,426

 

100%

$

133,714

 

100%

$

22,712

 

17%

Sales by geographic region

 

 

 

 

 

 

 

 

 

 

 

 

 

 

  

 

  

 

  

 

  

 

  

 

United States

 

$

34,723

 

26%

 

$

19,104

 

22%

 

$

15,619

 

82%

 

$

47,471

 

30%

$

45,162

 

34%

$

2,309

 

5%

EMEA

 

21,425

 

14%

 

13,625

 

10%

 

7,800

 

57%

China

 

15,197

 

12%

 

21,238

 

25%

 

(6,041

)

(28)%

 

30,381

19%

20,007

15%

10,374

 

52%

EMEA

 

17,243

 

13%

 

19,703

 

23%

 

(2,460

)

(12)%

 

Rest of APAC

 

56,922

 

37%

 

54,877

 

41%

 

2,045

 

4%

Rest of World

 

64,709

 

49%

 

25,437

 

30%

 

39,272

 

154%

 

 

227

 

-

 

43

 

-

 

184

 

*

Total

 

$

131,872

 

100%

 

$

85,482

 

100%

 

$

46,390

 

54%

 

$

156,426

 

100%

$

133,714

 

100%

$

22,712

 

17%

*

Not meaningful

30

Total salesSales increased across all market categories for the three months ended September 30, 2017March 31, 2022 against the comparable prior year period, drivenprimarily in the Semiconductor and Compound Semiconductor markets, partially offset by ongoing improvementsa decline in LED industry conditions, as well as additional sales from the Ultratech business acquired in May 2017, spread across all markets. Pricing was not a significant driver of the change in total sales.Data Storage market. By geography, sales increased in the United States and Rest of World regions, offset by decreases in China and EMEA. The most significant increase occurredacross all regions. Sales in the Rest of WorldAPAC region which was attributable tofor the increasedthree months ended March 31, 2022 included sales in Singapore and Taiwan of $23.9 million and $17.2 million, respectively. Sales in the LED Lighting, Display & Compound Semiconductor market in Malaysia, as well as additional sales fromRest of APAC region for the Ultratech business acquired. Additionally, increasedthree months ended March 31, 2021 included sales in the United States were primarily attributable to increased sales in the Scientific & Industrial market, as well as additional sales from the Ultratech business acquired.Taiwan, South Korea, and Thailand of $18.6 million, $10.8 million, and $9.2 million, respectively. We expect there will continue to be year-to-year variations in our future sales distribution across markets and geographies.

Orders increased to $161.9 million for In light of the three months ended September 30, 2017 from $118.0 million for the comparable prior year period. The increase in orders was primarily attributable to increasesglobal nature of our business, we are impacted by conditions in the LED Lighting, Display & Compound Semiconductorvarious countries in which we and Scientific & Industrial markets, including additional bookings from the Ultratech acquisition.our customers operate.

One of the performance measures we use as a leading indicator of the business is the book-to-bill ratio. The ratio is defined as orders recorded in a given period divided by revenue recognized in the same period. A ratio greater than one indicates we are adding orders faster than we are recognizing revenue. Gross Profit

For the three months ended September 30, 2017, the ratio was 1.2, compared to 1.4 for the comparable prior period. Our backlog at September 30, 2017 was $299.2 million, which was higher than the backlog at June 30, 2017 of $269.5 million. During the three months ended September 30, 2017, we recorded backlog adjustments of approximately $0.1 million relating to orders that no longer met our bookings criteria.

Gross Profit

In the third quarter of 2017,March 31, 2022, gross profit increased compared to the third quarter of 2016 due to a sharp increase in sales volume, including the acquisition of Ultratech. Gross margins remained relatively consistent for the three months ended September 30, 2017 against the comparable prior period primarily due to an increase in sales volume, as thewell as a slight increase in gross margins. Gross margins increased principally due to product and region mix of sales in the period, waspartially offset by increased logistics costs, as well as an inventory fair value step-up that was recordedincrease in connection withspending as we invested in service infrastructure and capacity expansion to meet the purchase accounting relating to the Ultratech acquisition. Given the current competitive environment in MOCVD business, we may see a decline ingrowing demands for our semiconductor product lines and supporting our evaluation systems at customers. We expect our gross margins as we move beyond this calendar year.to fluctuate each period due to product mix and other factors.

Research and developmentDevelopment

The markets we serve are characterized by continuous technological development and product innovation, and we invest in various research and development initiatives to maintain our competitive advantage and achieve our growth objectives. Research and development expenses increased for the three months ended March 31, 2022 against the comparable prior period primarily due to personnel-related expenses as we invest in the third quarternew research and development and additional applications for our technology in order to be well positioned to capitalize on emerging global megatrends and support longer term growth in Semiconductor and Compound Semiconductor markets. However, expenses as a percentage of 2017revenue have decreased when compared to the third quarter of 2016 primarily as a result of the addition of the acquired Ultratech related researchprior period.

Selling, General, and development projects, partially offset by our decision to significantly reduce investments in certain technology, as well as decreases in other personnel-related expenses and professional fees as a result of our initiative to streamline operations, enhance efficiency, and reduce costs.

Selling, general, and administrativeAdministrative

Selling, general, and administrative expenses increased for the three months ended March 31, 2022 against the comparable prior period primarily due to higher variable expenses associated with the additionincrease in revenue, profitability, and order in-take. However, expenses as a percentage of revenue have remained flat when compared to the acquired Ultratech relatedprior year period. Given the uncertainty regarding the impacts on our business resulting from the COVID-19 pandemic, we are focused on the proactive management of expenses. In future periods, we may incur additional selling, general and administrative costs, as well as increased professionalexpenses to support our responses to the COVID-19 pandemic. In addition, we are currently experiencing duplicate operating expenses for the transition from our existing facility in San Jose, California to our new leased facility, and legal fees.will continue to do so until this transition is completed over the next several quarters.

Amortization Expense

Amortization expense

The increase decreased compared to the comparable prior year period primarily due to changes in amortization expense is a resultto reflect expected cash flows of the additional intangibles acquired as part of the acquisition of Ultratech, offset by the lower amortization resulting from the impairment of the certain technologyintangible assets, in the prior year as well as certain other intangible assets becoming fully amortized during 2016.in 2021.

 

Restructuring expense

During 2016, we undertook restructuring activities as part of our initiative to streamline operations, enhance efficiencies, and reduce costs, as well as reducing future investments in certain technology development, which together impacted

approximately 75 employees. In addition, during 2017, we began the acquisition integration process to enhance efficiencies, resulting in additional employee terminations and other facility closing costs. Over the next few quarters, we expect to incur additional restructuring costs of $1 million to $5 million as it finalizes all of these activities.

Acquisition costs

Acquisition costs are non-recurring charges incurred in connection with the acquisition of the Ultratech business.

Asset Impairment

During the third quarter of 2016 we decided to significantly reduce investments in certain technologies and recorded non-cash asset impairment charges of $57.6 million, partially offset by an adjustment to our assessment of the fair market value of an asset then held as available-for-sale of $1.6 million.

Interest Income (Expense)

For the three months ended September 30, 2017, weWe recorded net interest expense of $4.7$2.8 million for the three months ended March 31, 2022, compared with net interest income of $0.3to $6.6 million infor the comparable prior year period. The changedecrease in interest expense was primarily relatesrelated to the Convertible Senioradoption of ASU 2020-06, as non-cash charges related to the amortization of debt discount and transaction costs of the 2023 Notes, issued2025 Notes, and 2027 Notes decreased approximately $3.3 million for the three months ended March 31, 2022 against the comparable prior period. Additionally, cash interest expense on the Notes decreased approximately $0.8 million from the comparable prior period due to the partial repurchase of the 2023 Notes in January 2017.November 2021.

31

Income Taxes

At the end of each interim reporting period, we estimate the effective income tax rate expected to be applicable for the full year. This estimate is used to determine the income tax provision or benefit on a year-to-date basis and may change in subsequent interim periods.

Our tax benefitexpense for the three months ended September 30, 2017March 31, 2022 was $1.8$0.4 million, compared to a tax expense of $1.1$0.3 million for the comparable prior year period. The 20172022 tax benefit included a $2.2 million benefit relating to our domestic operations and a $0.4 million expense relating to our non-U.S. operations, compared to 2016 when our expense included an expense of $0.3 million related to domestic operations and $0.8 million related to our non-U.S. operations. The currentoperations and $0.1 million related to our domestic operations, compared to the comparable period in 2021 when the expense included a $0.2 million expense related to our non-U.S. operations and $0.1 million related to our domestic tax benefit is primarily attributable to an income tax benefit for losses incurred duringoperations.

For the three months ended September 30, 2017, asMarch 31, 2022 and 2021, the Company’s U.S. deferred tax liability created by the issuance of the Convertible Senior Notes is treated as a source of income in fiscal 2017,assets are fully offset by a deferred provision related to tax amortization on indefinite-lived intangible assets.valuation allowance since the Company cannot conclude that it is more likely than not that these future benefits will be realized. The current period non-U.S. tax expense is attributable to the profitable non-U.S. operations. Thedomestic tax expense for the comparable periodboth periods is primarily attributable to the tax amortization of indefinite-lived intangible assets that is not available to offset U.S. deferred tax assets.

For the nine months ended September 30, 2017 and 2016

The following table presents operating results as a percentage of net sales, as well as period-over-period dollar and percentage changes for those line items. Our results of operations are reported as one business segment, including the Ultratech business acquired.

 

 

Nine months ended September 30,

 

Change

 

 

 

2017

 

2016

 

Period to Period

 

 

 

(dollars in thousands)

 

Net sales

 

$

341,324

 

100%

 

$

238,842

 

100%

 

$

102,482

 

43%

 

Cost of sales

 

215,344

 

63%

 

141,991

 

59%

 

73,353

 

52%

 

Gross profit

 

125,980

 

37%

 

96,851

 

41%

 

29,129

 

30%

 

Operating expenses, net

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

57,669

 

17%

 

63,545

 

27%

 

(5,876

)

(9)%

 

Selling, general, and administrative                           

 

71,574

 

21%

 

58,230

 

24%

 

13,344

 

23%

 

Amortization

 

21,722

 

6%

 

15,785

 

7%

 

5,937

 

38%

 

Restructuring

 

9,605

 

3%

 

3,993

 

2%

 

5,612

 

141%

 

Acquisition costs

 

16,277

 

5%

 

 

0%

 

16,277

 

*

 

Asset impairment

 

1,139

 

0%

 

69,662

 

29%

 

(68,523

)

(98)%

 

Other, net

 

(228

)

(0)%

 

884

 

0%

 

(1,112

)

(126)%

 

Total operating expenses, net

 

177,758

 

52%

 

212,099

 

89%

 

(34,341

)

(16)%

 

Operating income (loss)

 

(51,778

)

(15)%

 

(115,248

)

(48)%

 

63,470

 

*

 

Interest income (expense), net

 

(12,369

)

(4)%

 

713

 

0%

 

(13,082

)

*

 

Income (loss) before income taxes

 

(64,146

)

(19)%

 

(114,535

)

(48)%

 

50,389

 

*

 

Income tax expense (benefit)

 

(24,969

)

(7)%

 

2,677

 

1%

 

(27,646

)

*

 

Net income (loss)

 

$

(39,177

)

(11)%

 

$

(117,212

)

(49)%

 

$

78,035

 

*

 


* Not Meaningful

Net Sales

The following is an analysis of sales by market and by region:

 

 

Nine months ended September 30,

 

Change

 

 

 

2017

 

2016

 

Period to Period

 

 

 

(dollars in thousands)

 

Sales by market

 

 

 

 

 

 

 

 

 

 

 

 

 

LED Lighting, Display & Compound Semiconductor

 

$

170,546

 

51%

 

$

97,132

 

41%

 

$

73,414

 

76%

 

Advanced Packaging, MEMS & RF

 

55,756

 

16%

 

52,400

 

22%

 

3,356

 

6%

 

Scientific & Industrial

 

86,917

 

25%

 

83,510

 

35%

 

3,407

 

4%

 

Front-End Semiconductor

 

28,105

 

8%

 

5,800

 

2%

 

22,305

 

385%

 

Total

 

$

341,324

 

100%

 

$

238,842

 

100%

 

$

102,482

 

43%

 

Sales by geographic region

 

 

 

 

 

 

 

 

 

 

 

 

 

United States

 

$

73,256

 

21%

 

$

66,550

 

28%

 

$

6,706

 

10%

 

China

 

81,811

 

24%

 

54,621

 

23%

 

27,190

 

50%

 

EMEA

 

57,312

 

17%

 

61,999

 

26%

 

(4,687

)

(8)%

 

Rest of World

 

128,945

 

38%

 

55,672

 

23%

 

73,273

 

132%

 

Total

 

$

341,324

 

100%

 

$

238,842

 

100%

 

$

102,482

 

43%

 

Total sales increased across all market categories for the nine months ended September 30, 2017 against the comparable prior year period, driven by ongoing improvements in LED industry conditions, as well as additional sales from the Ultratech business acquired in May 2017, spread across all markets. Pricing was not a significant driver of the change in total sales. Sales also increased across most geographical regions, primarily due to the increased sales in the LED Lighting, Display & Compound Semiconductor market, as well as additional sales from the Ultratech acquisition. Increased sales in the Rest of World region was principally driven by a significant increase in sales to customers located in Malaysia. We expect there will continue to be year-to-year variations in our future sales distribution across markets and geographies.

Orders increased to $391.9 million for the nine months ended September 30, 2017 from $247.3 million for the comparable prior year period. The increase in orders was primarily attributable to an increase of over 80% in orders in the LED Lighting, Display, & Compound Semiconductor market, as well as a 41% increase in the Scientific & Industrial market.

One of the performance measures we use as a leading indicator of the business is the book-to-bill ratio. The ratio is defined as orders recorded in a given period divided by revenue recognized in the same period. A ratio greater than one indicates we are adding orders faster than we are recognizing revenue. For the nine months ended September 30, 2017 and September 30, 2016, the ratio was 1.1. Our backlog at September 30, 2017 was $299.2 million, which was higher than the backlog at December 31, 2016 of $209.2 million. During the nine months ended September 30, 2017, we increased backlog by approximately $41.6 million relating to backlog acquired from Ultratech, while adjusting for a decrease in backlog of approximately $1.7 million relating to orders that no longer met our bookings criteria.

Gross Profit

For the nine months ended September 30, 2017, gross profit increased compared to 2016 due to a sharp increase in sales volume, including the addition of the Ultratech acquisition, partially offset by decreased gross margins. Gross margins decreased principally due to an inventory fair value step-up that was recorded in connection with the purchase accounting relating to the Ultratech acquisition as well as product and region mix of sales in the period. Given the current competitive environment in MOCVD business, we may see a decline in gross margins as we move beyond this calendar year.

Research and development

The markets we serve are characterized by continuous technological development and product innovation, and we invest in various research and development initiatives to maintain our competitive advantage and achieve our growth objectives. Research and development expenses decreased for the nine months ended September 30, 2017 compared to 2016 primarily as a result of our decision to significantly reduce investments in certain technology, as well as decreases in other personnel-related expenses and professional fees as a result of our initiative to streamline operations, enhance efficiency, and reduce costs. These decreases were partially offset by the addition of the acquired Ultratech related research and development projects.

Selling, general, and administrative

Selling, general, and administrative expenses increased for the nine months ended September 30, 2017 compared to 2016 primarily due to the addition of the acquired Ultratech related selling, general and administrative costs.

Amortization expense

The increase in amortization expense is a result of the additional intangibles acquired as part of the acquisition of Ultratech, offset by the lower amortization resulting from the impairment of certain technology assets in the prior year as well as certain other intangible assets becoming fully amortized during 2016.

Restructuring expense

During 2016, we undertook restructuring activities as part of our initiative to streamline operations, enhance efficiencies, and reduce costs, as well as reducing future investments in certain technology development, which together impacted approximately 75 employees. In addition, during 2017, we began the acquisition integration process to enhance efficiencies, resulting in additional employee terminations and other facility closing costs. Over the next few quarters, we expect to incur additional restructuring costs of $1 million to $5 million as it finalizes all of these activities.

Acquisition costs

Acquisition costs are non-recurring charges incurred in connection with the acquisition of the Ultratech business, which included $4.2 million on non-cash charges related to accelerated share-based compensation for employee terminations for the nine months ended September 30, 2017.

Asset Impairment expense

During the nine months ended September 30, 2016, we recorded non-cash impairment charges of $57.6 million relating to our decision to significantly reduce investments in certain technologies, $5.9 million relating to our assessments of the fair market value of assets held for sale, and $6.1 million relating to the disposal of certain lab equipment. Impairment charges for the nine months ended September 30, 2017 primarily relate to assessments of the fair market value of assets held for sale.

Interest Income (Expense)

For the nine months ended September 30, 2017, we recorded net interest expense of $12.4 million compared with net interest income of $0.7 million in the prior year period.  The change primarily relates to the Convertible Senior Notes issued in January 2017.

Income Taxes

At the end of each interim reporting period, we estimate the effective income tax rate expected to be applicable for the full year. This estimate is used to determine the income tax provision or benefit on a year-to-date basis and may change in subsequent interim periods.

Our tax benefit for the nine months ended September 30, 2017 was $25.0 million compared to aforeign tax expense of $2.7 million for the comparable prior period. The 2017 tax benefit included $21.6 million relating to our domestic operations and $3.4 million relating to our non-U.S. operations, compared to 2016 when our expense included $1.2 million related to domestic operations and $1.5 million related to our non-U.S. operations. The current period domestic tax benefitboth periods is primarily attributable to an income tax benefit for losses incurred during the nine months ended September 30, 2017, as the deferred tax liability creatednon-U.S operations profits and foreign withholding taxes on unremitted earnings, offset by the issuance of the Convertible Senior Notes is treated as a source of income in fiscal 2017, offset by a deferred provision related to tax amortization on indefinite-lived intangible assets. The current period non-U.S. tax benefit is primarily attributable to the remeasurement of an uncertain tax position, which included the reversal of a previously established non-U.S. tax liability and the recognition of a deferred tax benefit related to certain foreign net operating losses generated in prior years that are now determined to be realizable, offset by tax expense attributed to the profitable non-U.S. operations. The tax expense for the comparable period is primarily attributable to the tax amortization of indefinite-lived intangible assets that is not available to offset U.S. deferred tax assets.

Liquidity and Capital Resources

Our cash and cash equivalents, restricted cash, and short-term investments and restricted cash are as follows:

March 31,

December 31,

    

2022

    

2021

 

September 30,

 

December 31,

 

 

2017

 

2016

 

 

(in thousands)

 

(in thousands)

Cash and cash equivalents

 

$

235,268

 

$

277,444

 

$

127,624

$

119,747

Restricted cash

 

688

 

725

Short-term investments

 

85,853

 

66,787

 

 

103,277

 

104,181

Total

 

$

321,121

 

$

344,231

 

$

231,589

$

224,653

A portion of our cash and cash equivalents is held by our subsidiaries throughout the world, frequently in each subsidiary’s respective functional currency, which is typically the U.S. dollar. At September 30, 2017March 31, 2022 and December 31, 2016,2021, cash and cash equivalents of $194.7$52.5 million and $149.2$38.3 million, respectively, were held outside the United States. In order to fund continued international growth, it isAs of March 31, 2022, we had $14.3 million of accumulated undistributed earnings generated by our current intention to permanently reinvestnon-U.S. subsidiaries for which the cashU.S. repatriation tax has been provided and cash equivalent balances held in China, Taiwan, and Malaysia, and our current forecasts dodid not require repatriationthe use of these fundscash due to the use of net operating loss carryforwards. Approximately $5.7 million of undistributed earnings will be subject to foreign withholding taxes if distributed back to the United States. At September 30, 2017, we had $143.9 million in cash held outside the United States on which we may have to pay significant U.S. income taxes to repatriate or utilize net operating loss carryforwards. Additionally, local government regulations may restrict our ability to move cash balances under certain circumstances. We currently do not expect such regulations and restrictions to impact our ability to make acquisitions, pay vendors, or conduct operations.

We believe that our projected cash flow from operations, combined with our cash and short term

short-term investments, will be sufficient to meet our projected working capital requirements, contractual obligations, and other cash flow needs for the next twelve months, including the scheduled interest payments on our Convertible Senior Notes issuedconvertible senior notes, purchase commitments, and payments in January 2017.respect of operating leases. Although there is uncertainty related to the anticipated impact of the COVID-19 outbreak on our future results, we believe our business model, our current cash and short-term investments, and our proactive management of expenses, leave us well-positioned to manage our business through this crisis as it continues to unfold.

32

A summary of the cash flow activity at September 30, 2017for the three months ended March 31, 2022 and 20162021 is as follows:

Cash Flows from Operating Activities

Three Months Ended March 31,

    

    

2022

    

2021

    

 

Nine months ended September 30,

 

 

2017

 

2016

 

 

(in thousands)

 

Net income (loss)

 

$

(39,177

)

$

(117,212

)

(in thousands)

Net income

$

13,330

$

2,494

Non-cash items:

 

 

 

 

 

Depreciation and amortization

 

32,295

 

26,010

 

 

6,240

 

6,822

Non-cash interest expense

 

7,641

 

 

 

238

 

3,514

Deferred income taxes

 

(21,235

)

1,529

 

 

(16)

 

(4)

Share-based compensation expense

 

19,976

 

12,133

 

 

4,481

 

3,237

Asset impairment

 

1,139

 

69,662

 

Provision for bad debts

 

99

 

160

 

Changes in operating assets and liabilities

 

14,538

 

(16,590

)

 

515

 

(5,578)

Net cash provided by (used in) operating activities

 

$

15,276

 

$

(24,308

)

$

24,788

$

10,485

Net cash provided by operating activities was $15.3$24.8 million for the ninethree months ended September 30, 2017March 31, 2022 and was due to the net lossincome of $39.2$13.3 million, plus adjustments for non-cash items of $39.9$10.9 million, offset byand an increase in cash flow from operating activities due to changes in operating assets and liabilities of $14.5$0.5 million. The changes in operating assets and liabilities were largely attributable to increases in inventories and prepaid expenses and other current assets, partially offset by increases in accounts payable and accrued expenses.

Cash Flows from Investing Activities

Three Months Ended March 31,

    

2022

    

2021

    

 

Nine months ended September 30,

 

 

2017

 

2016

 

 

(in thousands)

 

Acquisitions of businesses, net of cash acquired

 

$

(399,478

)

$

 

(in thousands)

Capital expenditures

 

(17,403

)

(10,717

)

$

(10,918)

$

(1,953)

Changes in investments, net

 

27,812

 

52,921

 

 

(238)

 

3,348

Other

 

2,284

 

463

 

Net cash provided by (used in) investing activities

 

$

(386,785

)

$

42,667

 

$

(11,156)

$

1,395

The net cash used inby investing activities during the ninethree months ended September 30, 2017March 31, 2022 was primarily attributable capital expenditures. We experienced increased capital expenditures as we finalized the build-out of our newly leased facility in San Jose, California. We expect a period of some duplicate operating expenses until the transition from our pre-existing facility to our new facility is completed. The cash provided by investing activities during the three months ended March 31, 2021 was primarily attributable to the net cash usedchanges in the acquisition of Ultratech as well asinvestments, partially offset by capital expenditures. As part of our efforts to streamline operations, enhance efficiency, and reduce costs, we are making certain investments in our facilities to support the consolidation activities, and, in 2017, we expect to incur future capital expenditures related to these activities of approximately $2 million to $5 million.

Cash Flows from Financing Activities

 

 

Nine months ended September 30,

 

 

 

2017

 

2016

 

 

 

(in thousands)

 

Settlement of equity awards, net of withholding taxes

 

$

(5,251

)

$

8

 

Purchases of common stock

 

 

(13,349

)

Proceeds from long-term debt borrowings

 

335,752

 

 

Repayments of long-term debt

 

(1,193

)

(252

)

Net cash provided by (used in) financing activities

 

$

329,308

 

$

(13,593

)

Three Months Ended March 31,

    

2022

    

2021

    

(in thousands)

Settlement of equity awards, net of withholding taxes

$

(5,789)

$

(747)

Net cash provided by (used in) financing activities

$

(5,789)

$

(747)

The cash provided by financing activities for the nine months ended September 30, 2017 was primarily related to the net cash proceeds received from the issuance of the Convertible Senior Notes in January 2017.

The cash used in financing activities for the ninethree months ended September 30, 2016March 31, 2022 and 2021 was primarily related to cash used to settle taxes related to employee equity programs, partially offset by cash received under the share repurchase program, which commenced in November 2015. There were no share repurchases in 2017.Employee Stock Purchase Plan.

Convertible Senior Notes

On January 10, 2017, we issued $345.0We have $20.2 million outstanding principal balance of 2.70% convertible senior unsecured notes due (the “Convertible Senior Notes”). We received net proceeds, after deducting underwriting discounts and fees and expenses payable by the Company, of approximately $335.8 million. The Convertible Senior Notesthat bear interest at a rate of 2.70% per year, payable semiannually in arrears on January 15 and July 15 of each year, commencing on July 15, 2017. The Convertible Senior Notesand mature on January 15, 2023, unless earlier purchased by the Company, redeemed, or converted. In addition, we have $132.5 million outstanding principal balance of 3.50% convertible senior notes that bear interest at a rate of 3.50% per year, payable

33

semiannually in arrears on January 15 and July 15 of each year, and mature on January 15, 2025, unless earlier purchased by the Company, redeemed, or converted. Finally, we have $125.0 million outstanding principal balance of 3.75% convertible senior notes that bear interest at a rate of 3.75% per year, payable semiannually in arrears on June 1 and December 1 of each year, and mature on June 1, 2027, unless earlier purchased by the Company, redeemed, or converted. The 2027 Notes are currently convertible by shareholders until June 30, 2022.

We believe that we have sufficient capital resources and cash flows from operations to support scheduled interest payments on this debt.these debts. In addition, we have access to a $150.0 million revolving credit facility (including an ability to request an additional $75.0 million, for a total commitment of no more than $225.0 million) to provide for our working capital needs and reimburse drawings under letters of credit and for other general corporate purposes. The Company has no immediate plans to draw down on the facility, which expires in December of 2026. Interest under the Facility is variable based on the Company’s secured net leverage ratio and is expected to bear interest based on SOFR plus a range of 150 to 225 basis points, if drawn. There is a yearly commitment fee of 25 to 35 basis points, based on the Company’s secured net leverage ratio, charged on the unused portion of the Facility.

Business Combination

As discussed above, on May 26, 2017, the Company acquired 100% of Ultratech, Inc., a leading supplier of lithography, laser-processing, and inspection systems used to manufacture semiconductor devices and LEDs. The results of Ultratech’s operations have been included in the consolidated financial statements since the date of acquisition.

Contractual Obligations and Commitments

We have commitments under certain contractual arrangements to make future payments for goods and services. These contractual arrangements secure the rights to various assets and services to be used in the future in the normal course of business. We expect to fund these contractual arrangements with cash generated from operations in the normal course of business.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements that have, or are reasonably likely to have, a current or future material effect on our financial condition, changes in financial condition, expenses, and results of operations, liquidity, capital expenditures or capital resources other than operating leases, bank guarantees, and purchase commitments disclosed in the preceding footnotes.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

Interest Rate Risk

Our exposure to market rate risk for changes in interest rates primarily relates to our investment portfolio. We centrally manage our investment portfolios considering investment opportunities and risks, tax consequences, and overall financing strategies. Our investment portfolio includes fixed-income securities with a fair value of approximately $85.9$103.3 million at September 30, 2017.March 31, 2022. These securities are subject to interest rate risk and, based on our investment portfolio at September 30, 2017,March 31, 2022, a 100 basis point increase in interest rates would result in a decrease in the fair value of the portfolio of $0.2$0.7 million. While an increase in interest rates may reduce the fair value of the investment portfolio, we will not realize the losses in the Consolidated Statements of Operations unless the individual fixed-income securities are sold prior to recovery or the loss is determined to be other-than-temporary.

Currency Exchange Risk

We conduct business on a worldwide basis and, as such, a portion of our revenues, earnings, and net investments in foreign affiliates is exposed to changes in currency exchange rates. The economic impact of currency exchange rate movements is complex because such changes are often linked to variability in real growth, inflation, interest rates, governmental actions, and other factors. These changes, if material, could cause us to adjust our financing and operating strategies. Consequently, isolating the effect of changes in currency does not incorporate these other important economic factors.

FromChanges in currency exchange rates could affect our foreign currency denominated monetary assets and liabilities and forecasted cash flows. We may enter into monthly forward derivative contracts from time to time we manage our risks and exposures to currency exchange rates throughwith the useintent of derivative financial instruments (e.g., forward contracts).mitigating a portion of this risk. We mainlyonly use derivative financial instruments in the context of hedging and generally do not use them for speculative purposes. During the third quarter of 2017, we had an immaterial amount ofpurposes and have not historically designated our foreign exchange derivatives designated as hedges. Accordingly, most foreign exchange derivatives are recorded in our Consolidated Balance Sheets at fair value and changes in fair value from these contracts are recorded inas “Other, net” in our Consolidated Statements of Operations. We execute derivative transactions with highly rated financial institutions to mitigate counterparty risk.

Our net sales to customers located outside of the United States represented approximately 74%70% and 79%66% of our total net sales for the three and nine months ended September 30, 2017, respectivelyMarch 31, 2022 and 78% and 72% for the comparable 2016 periods.2021, respectively. We expect that net sales to customers outside the United States will continue to represent a large percentage of our total net sales. Our sales denominated in currencies

34

other than the U.S. dollar represented 1% and 2%approximately 3% of total net sales infor both the three and nine months ended September 30, 2017, respectively,March 31, 2022 and 2% and 4% for the comparable 2016 periods.2021.

A 10% change in foreign exchange rates would have an immaterial impact on the consolidated results of operations since most of our sales outside the United States are denominated in U.S. dollars.

Item 4. Controls and Procedures

Management’s Report on Internal Control over Financial ReportingEvaluation of Disclosure Controls and Procedures

Our principal executive and financial officers have evaluated and concluded that our disclosure controls and procedures are effective as of September 30, 2017.March 31, 2022. The disclosure controls and procedures are designed to ensure that the information required to be disclosed in this report filed under the Securities Exchange Act of 1934 is recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and is accumulated and communicated to our principal executive and financial officers as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control overOver Financial Reporting

On May 26, 2017, we completedDuring the acquisition of Ultratech, Inc., and are integrating the acquired business into our overall internal control over financial reporting process. Management is in the process of assessing the internal control over financial reporting and is implementing or revising internal controls where necessary. See Note 3 to the Consolidated Financial

Statements — Business Combinations, for further details. Therequarter ended March 31, 2022, there were no other changes in internal control for the quarter ended September 30, 2017 that have materially affected or are reasonably likely to materially affect internal control over financial reporting.

PART II—OTHER INFORMATION

Item 1. Legal Proceedings

On September 21, 2017, Blueblade Capital Opportunities LLCJune 8, 2018, an Ultratech shareholder who received Veeco stock as part of the consideration for the Ultratech acquisition filed a purported class action complaint in the Superior Court of the State of California, County of Santa Clara, captioned Wolther v. Maheshwari et al., Case No. 18CV329690, on behalf of purported beneficial owners of 440,100himself and others who purchased or acquired shares of Veeco pursuant to the registration statement and prospectus which Veeco filed with the SEC in connection with the Ultratech common stock,acquisition (the “Wolther Action”). On August 2 and August 8, 2018, two purported class action complaints substantially similar to the Wolther Action were filed an action against Ultratechon behalf of different plaintiffs in Delaware Court of Chancery requesting an appraisalthe same court as the Wolther Action. These cases have been consolidated with the Wolther Action, and a consolidated complaint was filed on December 11, 2018. The consolidated complaint seeks to recover damages and fees under Sections 11, 12, and 15 of the valueSecurities Act of their Ultratech stock pursuant to 8 Del. C. §262.  The Company believes that the merger price, which was the product of arms-length negotiations, was fair and reasonable, and intends to contest the appraisal claim.  Discovery1933 for, among other things, alleged false/misleading statements in the matter has commenced.

On April 12, 2017, the Company filed a patent infringement complaint in the U.S. District Court for the Eastern District of New York against SGL Carbon, LLCregistration statement and SGL Carbon SE (collectively, “SGL”), alleging infringement of patents relating to wafer carrier technology used in MOCVD equipment.  The complaint alleges that SGL infringes Veeco’s patents by making and selling certain wafer carriers to Veeco’s competitor, Advanced Micro-Fabrication Equipment, Inc. (“AMEC”). On November 2, 2017, the U.S. District Court granted the Company’s motion for a preliminary injunction prohibiting SGL from shipping wafer carriers using the Company’s patented technology without the Company’s express authorization. The Company continues to seek a post-trial permanent injunction and monetary damages against SGL.

On July 13, 2017, AMEC filed a patent infringement complaint against Veeco Instruments Shanghai Co., Ltd. (“Veeco Shanghai”) with the Fujian High Court in China, alleging that the Company’s MOCVD products infringed a Chinese utility model patentprospectus relating to the synchronous movement engagement mechanismUltratech acquisition, relating primarily to the alleged failure to disclose delays in the advanced packaging business, increased MOCVD competition in China, and an intellectual property dispute. In October 2021, Veeco and the court-appointed class representatives signed an agreement to settle the Wolther Action on a chemical vapor deposition reactorclass-wide basis for $15.0 million, subject to court approval and seeking injunctive reliefclass members’ opportunity to object and monetary damages againstopt-out. The settlement amount will be funded by insurance carriers.

On December 21, 2018, a purported Veeco Shanghai. The Company believes this complaint is without merit and intends to vigorously defend against these allegations. The Company hasstockholder filed a petition for invalidation of this patent withderivative action in the Chinese Patent Reexamination Board (“PRB”).  The Fujian HighSuperior Court has suspended the infringement case against Veeco pending the outcome of the invalidation proceeding atState of California, County of Santa Clara, captioned Vladimir Gusinsky Revocable Trust v. Peeler, et al., Case No. 18CV339925, on behalf of nominal defendant Veeco. The complaint seeks to assert claims for breach of fiduciary duty, waste of corporate assets, and unjust enrichment against current and former Veeco directors premised on purported misstatements and omissions in the PRB.registration statement relating to the Ultratech acquisition. Veeco is defending this matter vigorously. On January 25, 2021, the court granted the defendants’ demurrer without leave to amend effecting the dismissal of the case. On March 26, 2021, plaintiff filed its notice of appeal of the trial court’s order granting defendants’ demurrer without leave to amend. In April 2022, Veeco and plaintiff reached an agreement in principle to settle the Derivative Action subject to court approval. As part of the settlement and subject to court approval, Veeco will make certain revisions to its internal Disclosure Committee Charter and its director education program. The agreement also provides that, subject to court approval, plaintiff will receive $0.3 million for fees and expenses. This amount will be funded by insurance that Veeco maintains in the normal course of its business.

35

The Company is involved in various other legal proceedings arising in the normal course of business. The Company does not believe that the ultimate resolution of these matters will have a material adverse effect on its consolidated financial position, results of operations, or cash flows.

Item 1A. Risk Factors

Information regarding risk factors appears in the Safe Harbor Statement at the beginning of this quarterly report on Form 10-Q and in Part I — Item 1A of our 20162021 Form 10-K.10-K. There have been no material changes from the risk factors previously disclosed, except as follows:

We are exposed to risks of operating businesses outside the United States.

A majority of our sales are to customers, and significant elements of our supply chain are from suppliers, who are located outside of the United States, which we expect to continue in the future. Our non-U.S. sales and operations are subject to risks inherent in conducting business outside the United States, many of which are beyond our 2016 Form 10-K.control including:

political and social attitudes, laws, rules, regulations, and policies within countries that favor local companies over U.S. companies, including government-supported efforts to promote local competitors;

global trade issues and uncertainties with respect to trade policies, including tariffs, trade sanctions, and international trade disputes, and the ability to obtain required import and export licenses;

differing legal systems and standards of trade which may not honor our intellectual property rights and which may place us at a competitive disadvantage;

pressures from foreign customers and foreign governments for us to increase our operations and sourcing in the foreign country, which may necessitate the sharing of sensitive information and intellectual property rights;

multiple conflicting and changing governmental laws and regulations, including varying labor laws and tax regulations;

reliance on various information systems and information technology to conduct our business, making us vulnerable to cyberattacks by third parties or breaches due to employee error, misuse, or other causes, that could result in business disruptions, loss of or damage to our intellectual property and confidential information (and that of our customers and other business partners), reputational harm, transaction errors, processing inefficiencies, or other adverse consequences;

regional economic downturns, varying foreign government support, unstable political environments, and other changes in foreign economic conditions;

the impact of public health epidemics, such as the COVID-19 pandemic, on employees, suppliers, customers and the global economy;

difficulties in managing a global enterprise, including staffing, managing distributors and representatives, and repatriating cash;

longer sales cycles and difficulties in collecting accounts receivable; and

different customs and ways of doing business.

Global conditions and other factors, such as the COVID-19 pandemic, the current conflict in Ukraine, and attendant transportation and freight cost challenges, have resulted in, and may continue to result in, a shortage of parts, materials

36

and services needed to manufacture and timely deliver our products.  These conditions have negatively impacted our suppliers’ ability to meet our demand requirements and, in turn, our ability to satisfy our customer demand.  Parts shortages have required, and may continue to require, that we plan ahead further than usual, and increase our purchase commitments to secure critical components in a timely manner.  These challenges, together with other challenges associated with operating an international business, may adversely affect our ability to recognize revenue, our gross margins on the revenue we do recognize, and our other operating results. 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None.

On October 28, 2015, our Board of Directors authorized a program to repurchase up to $100 million of our common stock to be completed through October 28, 2017. At September 30, 2017, $22.3 million of the $100 million had been utilized. No repurchases occurred after the first quarter of 2016. Repurchases may be made from time to time on the open market or in privately negotiated transactions in accordance with applicable federal securities laws. The timing and amount of future repurchases, if any, will depend upon market conditions, SEC regulations, and other factors. The repurchases would be funded using available cash balances and cash generated from operations. The program does not obligate us to acquire any particular amount of common stock and may be modified or suspended at any time at our discretion.

Item 3. Defaults uponUpon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not Applicable.

Item 5. Other Information

None.

37

Item 6. Exhibits

Unless otherwise indicated, each of the following exhibits has been filed with the Securities and Exchange Commission by Veeco under File No. 0-16244.

Exhibit

Incorporated by Reference

Filed or
Furnished

Number

    

Exhibit Description

    

Incorporated by ReferenceForm

    

Filed or
Furnished

NumberExhibit

    

Exhibit DescriptionFiling Date

    

FormHerewith

Exhibit

Filing Date

Herewith

10.1

Form of Notice of Performance Restricted Stock Unit Award and related terms and conditions pursuant to the Veeco Amended and Restated 20102019 Stock Incentive Plan, effective March 3, 2017.2022.

*

10.2

Form of Notice of Restricted Stock Award and related terms and conditions pursuant to the Veeco 2019 Stock Incentive Plan, effective March 2022.

*

31.1

Certification of Chief Executive Officer pursuant to Rule 13a—14(a) or Rule 15d—14(a) of the Securities and Exchange Act of 1934.

*

31.2

Certification of Chief Financial Officer pursuant to Rule 13a—14(a) or Rule 15d—14(a) of the Securities and Exchange Act of 1934.

*

32.1

Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes - Oxley Act of 2002.

*

32.2

Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes - Oxley Act of 2002.

*

101.INS

XBRL Instance.Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

**

101.XSD

XBRL Schema.

**

101.PRE

XBRL Presentation.

**

101.CAL

XBRL Calculation.

**

101.DEF

XBRL Definition.

**

101.LAB

XBRL Label.

**


*104

Filed herewithCover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

**

**

Filed herewith electronically

*     Filed herewith

**   Filed herewith electronically

38

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on November 3, 2017.May 9, 2022.

Veeco Instruments Inc.

By:

/S/ JOHN R. PEELERWILLIAM J. MILLER, Ph.D.

John R. PeelerWilliam J. Miller, Ph.D.

Chairman and Chief Executive Officer

By:

/s/ SHUBHAM MAHESHWARIJOHN P. KIERNAN

Shubham MaheshwariJohn P. Kiernan

ExecutiveSenior Vice President and Chief Financial Officer

40


39